Introduction
============

The organization of eukaryotic cells depends on bidirectional membrane trafficking along microtubules (MTs; [@bib81]). Anterograde transport along MTs is mediated predominantly by kinesin-1, the founding member of the kinesin superfamily ([@bib8]; [@bib73]), and kinesin-3. Kinesins are opposed by cytoplasmic dynein that moves cargo toward MT minus ends ([@bib72]; [@bib74]; [@bib27]). Kinesins and dynein bind to the same organelle, where they compete with each other in a "tug-of-war" to determine the direction of transport ([@bib23]; [@bib81]; [@bib51]; [@bib60]; [@bib25]; [@bib31]). Recent experimental evidence both in vitro ([@bib15]) and in living cells ([@bib39]) suggests that additional higher order control modulates the tug-of-war, thereby orchestrating bidirectional transport ([@bib31]). Indeed, cargo-bound adapter complexes have been reported that bind and coordinate both kinesin-1 and dynein ([@bib13]; [@bib9]; [@bib2]; [@bib18]; [@bib62]; [@bib50]; [@bib19]; [@bib75]). However, 8 of the 45 reported kinesins in mice and humans are kinesin-3 motors ([@bib49]), and these motors play pivotal roles in axonal transport ([@bib14]) and motility of early endosomes (EEs; [@bib28]). Despite this importance, no coordinating adapter is known for kinesin-3 and dynein.

The fungus *Ustilago maydis* is a genetically tractable organism that shares remarkable conservation with human cells ([@bib64]). This includes the use of kinesin-3 and dynein for bidirectional EE motility ([@bib80]; [@bib40]). Anterograde EE transport is driven by three to six kinesin-3 motors, whereas retrograde movement is mediated by single dyneins, which change the direction of EE transport upon binding ([@bib57]). Here, we report that a Hook protein, Hok1, is essential for EE motility. Hook proteins have previously been reported as organelle--MT linkers, involved in endocytic protein trafficking, Golgi organization, and cilia formation, but have not been implicated in bidirectional transport ([@bib37], [@bib38]; [@bib67]; [@bib77]; [@bib22]; [@bib3]; [@bib46]). We show that Hok1 forms a complex with homologues of the human fused toes (FTS) protein ([@bib41]) and its interactor FTS- and Hook-interacting protein (FHIP; [@bib83]). A conserved coiled-coil (CC) domain within the N-terminal region of Hok1 controls both dynein and kinesin-3 attachment to EEs. A change from anterograde to retrograde transport is accompanied by kinesin-3 release. When considered together, our results suggest that Hok1 is part of an adapter complex that orchestrates bidirectional transport by coordinating kinesin-3 and dynein attachment to EEs.

Results
=======

Identification of factors involved in bidirectional EE motility
---------------------------------------------------------------

We identified mutants defective in EE motility by screening *U. maydis* for impaired growth morphology. Normal wild-type hyphae elongate and carry a central nucleus ([Fig. S1 A](http://www.jcb.org/cgi/content/full/jcb.201309022/DC1){#supp1}). Dynein and kinesin-3 mediate bidirectional EE motility along MTs ([@bib40]). These are unipolar near the tip and septum, extending their plus ends to the cell poles, but form bipolar bundles in the center of cells, with their minus ends concentrated near the nucleus (Fig. S1 B; [@bib56]). Consequently, inactivation of either dynein or kinesin-3 leads to unidirectional transport mediated by the opposite motor. This, in turn, results in largely immobile clusters of EEs near the cell tip ([Fig. S2 A](http://www.jcb.org/cgi/content/full/jcb.201309022/DC1){#supp2}, a dynein heavy chain mutant Dyn2^ts^; [@bib79]) or in subapical regions (Fig. S2 A, kinesin-3 mutant ΔKin3; [@bib40]). On agar medium plates, colonies of wild type are white and filamentous (Fig. S2 B). Impaired EE motility results in short hyphae and gray colonies (Fig. S2, B and C, ΔKin3 shown as an example). We exploited the appearance of this EE motility--associated morphological phenotype to screen for UV-induced mutants expressing the EE-specific small GTPase Rab5a fused to GFP ([@bib21]). We selected strains that (a) appear gray, (b) form short hyphal cells, and (c) show EE motility defects ([Fig. S2](http://www.jcb.org/cgi/content/full/jcb.201309022/DC1){#supp3}), identifying an endosome motility defect mutant (EMD5; [Figs. 1 A](#fig1){ref-type="fig"} and S2 B, EMD5). Whereas EEs are motile and evenly distributed in wild type ([Fig. 1 B](#fig1){ref-type="fig"} and [Video 1](http://www.jcb.org/cgi/content/full/jcb.201309022/DC1){#supp4}), EE motility in EMD5 was almost abolished, and organelles clustered at the cell ends ([Fig. 1 B](#fig1){ref-type="fig"}, EMD5, arrowheads and asterisk indicate EE clusters). This is reminiscent of a defect in retrograde, dynein-mediated motility (Fig. S2 A).

![**Hok1 is required for EE motility.** (A) Morphology of wild type and Δ*hok1* mutants. (B) EE distribution and motility in wild type, EMD5 mutants expressing *hok1* (EMD5 + Hok1), and Δ*hok1* mutants (Δ*hok1*). Deletion or mutation of *hok1* abolishes motility and induces EE clusters (arrowheads; asterisk in kymograph). Contrast-inverted kymographs show GFP-Rab5a fluorescence (EEs). See also [Video 1](http://www.jcb.org/cgi/content/full/jcb.201309022/DC1){#supp5}. (C) Domain organization of selected Hook proteins. For accession numbers, see Materials and methods. (D) Contrast-inverted kymographs showing bidirectional motility of mCherry-Rab5a--labeled EEs and Hok1-GFP. Hok1 locates on all moving organelles (yellow lines in merged image). See also [Video 2](http://www.jcb.org/cgi/content/full/jcb.201309022/DC1){#supp6}. Images in A, B, and D were adjusted in brightness, contrast, and γ settings. Horizontal bars are in micrometers, and vertical bars are in seconds.](JCB_201309022_Fig1){#fig1}

A Hook protein is required for EE motility
------------------------------------------

We performed whole genome sequencing of EMD5 and identified 11 point mutations. Two resided in the open reading frame Um05551.1 (E~843~ to K and G~883~ to E; see Materials and methods for accession numbers; [@bib33]). The predicted protein shares 22.1/38% and 23.0/39.1% sequence identity/similarity with a Hook from *Drosophila melanogaster* and Hook1 from humans, respectively. In addition, it displays a similar domain architecture ([Fig. 1 C](#fig1){ref-type="fig"}), containing an N-terminal Hook superfamily domain (P = 8.9 × 10^−38^) and an extended CC region ([Fig. 1 C](#fig1){ref-type="fig"}). Um05551.1 was named Hok1 following standard nomenclature rules (see gene nomenclature conventions in the *Saccharomyces* Genome Database). Similar to *D. melanogaster*, the *U. maydis* genome encodes only one Hook protein. When expressed in EMD5, Hok1 rescued the mutant growth defect and restored EE motility ([Figs. 1 B](#fig1){ref-type="fig"} and S2 D and Video 1). We confirmed the importance of Hok1 for EE motility deleting *hok1*. This Δ*hok1* mutant grew identically to EMD5 with short, bipolar cells that contained polar clusters of largely immobile GFP-Rab5a--positive EEs ([Fig. 1, A and B](#fig1){ref-type="fig"}, indicated by arrowheads). Introducing a fusion protein of Hok1 and GFP into the Δ*hok1* mutant restored hyphal growth and EE motility ([Figs. 1 A](#fig1){ref-type="fig"} and S2 E). We conclude that Hok1 is required for bidirectional motility of EEs. When expressed in Δ*hok1*, the Hok1-GFP fusion protein was located on both anterograde- and retrograde-moving EEs ([Fig. 1 D](#fig1){ref-type="fig"} and [Video 2](http://www.jcb.org/cgi/content/full/jcb.201309022/DC1){#supp7}). This suggests that Hok1 controls EE motility while bound to the organelles.

The C-terminal part of Hok1 targets to EEs
------------------------------------------

Loss-of-function mutations in *hok1* were located in a conserved stretch of amino acids near the C terminus. This region targets human Hook3 to the Golgi apparatus ([@bib77]). The N terminus of human Hook proteins interacts with MTs ([@bib77]) or, in the case of ZYG-12 from worms, binds the dynein complex ([@bib47]). We therefore divided Hok1 into three analogous regions ([Fig. 2 A](#fig2){ref-type="fig"}, N-terminal part, aa 1--224; middle part, aa 225--624; and C-terminal part, aa 625--930) and fused these individual domains to GFP and tested their localization pattern. We expressed the fusion proteins in Δ*hok1* mutants, containing mCherry-Rab5a, to avoid dimerization or competition with endogenous Hok1. Each fusion protein was expressed ([Fig. S3 A](http://www.jcb.org/cgi/content/full/jcb.201309022/DC1){#supp8}), but none of the truncated proteins rescued the Δ*hok1* phenotype ([Fig. 2 B](#fig2){ref-type="fig"}). Neither Hok1^1--224^ nor Hok1^225--624^ showed specific localization in the cell ([Figs. 2 C](#fig2){ref-type="fig"} and [S4 A](http://www.jcb.org/cgi/content/full/jcb.201309022/DC1){#supp9}), suggesting that the N-terminal domain of Hok1 has no strong affinity for either EEs or MTs. In contrast, Hok1^625--930^ localized to the apical EE cluster ([Fig. 2 C](#fig2){ref-type="fig"}), indicating that the C-terminal region targets Hok1 to EEs. To determine whether this is the only role of the C-terminal region, we generated a C-terminal--truncated Hok1 protein ([Fig. 2 D](#fig2){ref-type="fig"}, Hok1^1--624^). This protein was expressed (Fig. S3 B) but neither bound to EEs ([Fig. 2 C](#fig2){ref-type="fig"}) nor complemented Δ*hok1* ([Fig. 2 E](#fig2){ref-type="fig"}). However, when Hok1^1--624^ was fused to the Phox (PX) domain of the endosomal t-SNARE Yup1 ([Fig. 2 D](#fig2){ref-type="fig"}; [@bib78]), the chimeric Hok1^1--624^PX protein was targeted to moving EEs ([Fig. 2 F](#fig2){ref-type="fig"} and [Video 3](http://www.jcb.org/cgi/content/full/jcb.201309022/DC1){#supp10}) and partially restored growth in Δ*hok1* (hyphal cell length of Δ*hok1 +* Hok1: 80.47 ± 16.03 µm, *n* = 283 cells; length of Δ*hok1* + Hok1^1--624^PX: 45.69 ± 22.9 µm, *n* = 504 cells; length of Δ*hok1*: 31.40 ± 7.04 µm, *n* = 268 cells; Δ*hok1* + Hok1^1--624^PX significantly longer than Δ*hok1*, P \< 0.0001; [Fig. 2 E](#fig2){ref-type="fig"}). We conclude that the C-terminal region of Hok1 anchors the protein to its cargo, which confirms findings in humans ([@bib77]). Artificial targeting of the remaining N-terminal part of Hok1 to EEs partially restored the morphology phenotype, suggesting that this part is essential for regulating EE motility.

![**The C-terminal region of Hok1 targets to endosomes.** (A) The organization of human Hook3, Hok1, and the truncated proteins Hok1^1--224^, Hok1^225--624^, and Hok1^625--930^. (B) Morphology of Δ*hok1* expressing Hok1^1--224^, Hok1^225--624^, and Hok1^625--930^. (C) Colocalization of Hok1^1--224^, Hok1^225--624^, Hok1^625--930^, and Hok1^1--624^ and mCherry-Rab5a--labeled EEs in Δ*hok1*. The cell edge is indicated in blue. Only the C-terminal fragment of Hok1 localizes to apical EE clusters. (D) Organization of Hok1^1--624^ and Hok1^1--624^PX. The latter carries an EE-targeting PX domain ([@bib78]). (E) Morphology of control cells and Δ*hok1* that express Hok1, Hok1^1--624^, and Hok1^1--624^PX. Targeting of truncated Hok1 to EEs partially rescues the growth defect. (F) Bidirectional motility of mCherry-Rab5a--labeled EEs and Hok1^1--624^PX. The upper two kymographs are contrast inverted. Hok1^1--624^PX locates on the moving organelles (yellow lines in merged image). See also [Video 3](http://www.jcb.org/cgi/content/full/jcb.201309022/DC1){#supp11}. Images in B, C, E, and F were adjusted in brightness, contrast, and γ settings. Horizontal bars are in micrometers, and the vertical bar is in seconds.](JCB_201309022_Fig2){#fig2}

Hok1 mediates binding of dynein to EEs
--------------------------------------

Δ*hok1* mutants showed short hyphae and apical EE clustering, reminiscent of dynein mutants (Fig. S2 A; [@bib40]). This suggests that Hok1 supports retrograde dynein-dependent motility of EEs. To test this idea, we coexpressed a functional fusion protein of the dynein heavy chain Dyn2 with a triple GFP tag (GFP~3~-Dyn2; [@bib40]) and mCherry-Rab5a in Δ*hok1*. Consistent with a previous study, we found that dynein accumulated at apical MT plus ends ([@bib55]), from where it moved toward MT minus ends located in the subapical region of the cell ([Figs. 3 A](#fig3){ref-type="fig"}, asterisk indicates dynein cluster; and S4 B; and [Video 4](http://www.jcb.org/cgi/content/full/jcb.201309022/DC1){#supp12}). We used fluorescent nuclear porins as internal calibration standards ([@bib57]) and confirmed a previous study that these retrograde signals represent individual dynein motors ([Fig. 3 B](#fig3){ref-type="fig"}) that carry EEs to the cell center ([@bib57]). In contrast, no dynein was found on anterograde EEs (Fig. S4 C; [@bib57]). The retrograde flux of dynein was not significantly different between Δ*hok1* and control cells (P = 0.09; [Fig. 3 C](#fig3){ref-type="fig"}), demonstrating that Hok1 is dispensable for retrograde dynein motility. However, dynein was not able to move EEs to MT minus ends in Δ*hok1* ([Fig. 3 A](#fig3){ref-type="fig"}, EEs), suggesting that Hok1 mediates the association of the motor with organelles. To confirm this, we treated Δ*hok1* cells with the MT-depolymerizing drug benomyl, a nocodazole-like, fungal-specific benzimidazole carbamate that binds to β-tubulin ([@bib12]; [@bib32]). In contrast to nocodazole, benomyl reversibly disrupts MTs in *U. maydis* ([@bib20]). When MTs were disrupted, apical dynein accumulation disappeared, whereas EE clusters were unaffected, and no colocalization with dynein fluorescence was observed under these conditions ([Fig. 3 D](#fig3){ref-type="fig"}). Collectively, these data suggest that dynein is not associated with EEs in the absence of Hok1.

![**The N-terminal region of Hok1 mediates dynein binding to EEs.** (A) GFP~3~-labeled dynein heavy chain (dynein) and mCherry-Rab5a--labeled endosomes (EEs) in Δ*hok1* mutants. Dynein (asterisk) accumulates at the cell tip (tip), from where it leaves without EEs. Cells were photobleached (bleach) to reduce signal interferences, which did not affect EE or motor motility ([@bib57]). See also [Video 4](http://www.jcb.org/cgi/content/full/jcb.201309022/DC1){#supp13}. (B) Estimated dynein numbers in moving GFP~3~-Dyn2 signals in control and Δ*hok1* cells. Estimation used an internal calibration standard, assuming that the GFP~3~-labeled dynein heavy chain forms dimers ([@bib57]). Data represent two experiments. The red line shows a normal distribution curve. (C) Retrograde dynein flux in control and Δ*hok1* cells at ∼10 µm behind the tip. Bars represent data from two experiments and are means ± SE; sample size is indicated. No significant difference was found, P = 0.09. (D) Images and linescan plot of dynein and EE colocalization in Δ*hok1* hyphal tips after disruption of the MTs (+benomyl). The dotted line in merged image indicates the region of intensity scan. a.u., arbitrary unit. (E) Motility of Hok1^1--624^ and mCherry-Rab5a--labeled EEs in Δ*hok1*. Hok1^1--624^ moves in retrograde direction, whereas EEs remain stationary. See also [Video 5](http://www.jcb.org/cgi/content/full/jcb.201309022/DC1){#supp14}. (F) Retrograde flux of Hok1 and Hok1^1--624^ at ∼10 µm behind the cell tip. Bars represent data from two experiments and are means ± SE; sample size is indicated. Significant difference is indicated: \*\*\*, P \< 0.0001. (G) Co-migration of Hok1^1--624^ and mCherry~3~-labeled dynein heavy chain. Kymographs were slightly misaligned to better show colocalization. See also [Video 6](http://www.jcb.org/cgi/content/full/jcb.201309022/DC1){#supp15}. (H) Domain organization of proteins used in immunoprecipitation and mass spectrometry experiments. Images in A, D, E, and G were adjusted in brightness, contrast, and γ settings. Horizontal bars are in micrometers, and vertical bars are in seconds.](JCB_201309022_Fig3){#fig3}

Our results showed that the N-terminal domain and the CC region of Hok1, when targeted to EEs, are sufficient to restore EE motility, suggesting that Hok1^1--624^ interacts with dynein. We therefore coexpressed Hok1^1--624^ and mCherry-Rab5a in a Δ*hok1* mutant and, consistent with the lack of the organelle-binding C terminus, found that EEs are immobile ([Fig. 3 E](#fig3){ref-type="fig"}, EEs in red). However, Hok1^1--624^ moved in a retrograde direction ([Fig. 3, E and F](#fig3){ref-type="fig"}; and [Video 5](http://www.jcb.org/cgi/content/full/jcb.201309022/DC1){#supp16}), suggesting that the N-terminal half of Hok1 interacts with dynein independently of its association with EEs. Indeed, Hok1^1--624^ and mCherry~3~-labeled dynein heavy chain traveled together in Δ*hok1* cells ([Fig. 3 G](#fig3){ref-type="fig"} and [Video 6](http://www.jcb.org/cgi/content/full/jcb.201309022/DC1){#supp17}), suggesting that the dynein--dynactin complex interacts with Hok1. To investigate this potential interaction further, we performed immunoprecipitation experiments followed by mass spectrometry, using truncated Hok1^1--624^ and the entire Hok1. Neither Hok1^1--624^ nor the entire Hok1 revealed any interaction with dynein--dynactin or any other motor protein. Instead, Hok1 interacted with the *U. maydis* proteins um00451 and um10821 (8--26 peptides; see Materials and methods for accession numbers). Both proteins show significant amino acid sequence similarity with human FTS (17.1% identity/27.4% similarity; [@bib41]) and human FHIP (18.9% identity/27.5% similarity; [@bib83]), respectively, and share a similar domain structure (Fig. S4 D, *U. maydis* FTS named Fts1 and *U. maydis* FHIP named Fhp1). Both proteins also bound to Hok1^225--930^ (8--19 peptides; [Fig. 3 H](#fig3){ref-type="fig"}) but only weakly to Hok1^625--930^ (two to five peptides) and Hok1^1--624^ (less than two peptides; [Fig. 3 H](#fig3){ref-type="fig"}), indicating that Hok1 binding requires both the C terminus and the middle region. Consistent with binding to Hok1 in vitro, we found that fluorescent Fts1-GFP and Fhp1-GFP localized to mCherry-Rab5a--labeled EEs (Fig. S4 E). We conclude that Hok1, Fts1, and Fhp1 form a complex, which was previously reported in humans ([@bib83]). Whether Fts1 or Fhp1 mediate interaction with dynein on organelles remains to be investigated.

A conserved region within the extended CC is crucial for dynein recruitment to EEs
----------------------------------------------------------------------------------

We asked whether the N-terminal or middle part of Hok1 is sufficient to bind dynein and restore filamentous growth of Δ*hok1*. We generated mutant proteins, missing either the middle region (Hok1^Δ225--624^) or consisting of the N-terminal 224 aa fused to the PX domain of Yup1 (Hok1^1--224^PX). In addition, we deleted the N-terminal region (Hok1^225--930^; [Fig. 4 A](#fig4){ref-type="fig"}). All proteins localized to EEs ([Fig. 4 B](#fig4){ref-type="fig"}), but none were able to restore filamentous growth of Δ*hok1* mutants ([Fig. 4 C](#fig4){ref-type="fig"}). Thus, both regions of Hok1 cooperate in dynein binding and motility control. All Hook proteins contain an extended CC domain of 260--280 aa, adjacent to the N-terminal Hook superfamily domain ([Fig. 1 C](#fig1){ref-type="fig"}; [@bib77]). Hok1 shares sequence identity with the human orthologues Hook1 and Hook3 (∼23.6 and ∼23.7%, respectively). Sequence conservation was highest within a central part of the CC region (50.9% identity and 75.7% similarity between Hok1 and Hook3 in a central stretch of 53 aa; Hook1: 37.7% identity and 69.8% similarity; [Fig. 4 D](#fig4){ref-type="fig"}). Within this conserved region, 18 of 25 identical residues are charged, suggesting that they are surface exposed and so could interact with a binding partner. We tested for the importance of this region by introducing short deletions into the conserved region ([Fig. 4 D](#fig4){ref-type="fig"}). The resulting mutant proteins Hok1^Δ361--385^ and Hok1^Δ333--355^ were expressed in Δ*hok1* mutants ([Figs. 4 E](#fig4){ref-type="fig"} and S3, B and C). Both localized to polar EE clusters ([Fig. 4 B](#fig4){ref-type="fig"}), but neither was able to restore EE motility or cell growth ([Figs. 4, C and F](#fig4){ref-type="fig"}; and [S5 A](http://www.jcb.org/cgi/content/full/jcb.201309022/DC1){#supp18}). This demonstrates that the highly conserved CC region is essential to the function of Hok1. As human Hook3 forms homodimers ([@bib37]; [@bib83]), we tested whether deletions in the CC region prevent dimerization, thereby inactivating Hok1. Native gel electrophoresis did not reveal differences between Hok1, Hok1^Δ361--385^, and Hok1^Δ333--355^ (Fig. S5 B), suggesting that small truncations do not alter protein tertiary structure. Thus, we consider it likely that the conserved region of Hok1 interacts with a functionally important binding partner.

![**A conserved region in the first CC is essential for Hok1 function.** (A) Organization of truncated Hok1^Δ225--624^, Hok1^1--224^PX, which carries an EE-targeting PX domain, and Hok1^225--930^. (B) Colocalization of truncated Hok1 proteins and mCherrry-Rab5a--labeled EEs in Δ*hok1* and colocalization of Hok1-GFP and EEs in cells expressing the peptide pHk^361--385^. Cell edges are indicated in blue. All constructs localize to EEs without rescuing Δ*hok1*. (C) Morphology of Δ*hok1* mutants expressing Hok1^Δ225--624^, Hok1^1--224^PX, Hok1^225--930^, and Hok1^Δ361--385^. Neither rescues the morphology defect. (D) Localization of a highly conserved region within the first CC of Hok1 and human Hook3. Identical amino acids are shown in light blue, and similar amino acids are shown in pink. The alignment was generated in ClustalW. H.s., *Homo sapiens*; U.m., *U. maydis*. (E) Organization of the truncated proteins Hok1^Δ361--385^ and Hok1^Δ333--355^. (F) Anterograde and retrograde flux of mCherry-Rab5a--labeled EEs in control cells and Hok1^Δ361--385^ and Hok1^Δ333--355^ (Δ333--355 and Δ361--385) at ∼10 µm behind the cell tip. Bars represent data from two experiments and are means ± SE; sample size is indicated. (G) Anterograde and retrograde flux of mCherry-Rab5a--labeled EEs in control cells and cells expressing the peptide pHk^361--385^ (see D for sequence). Bars represent data from two experiments and are means ± SE; sample size is indicated. Images in B and C were adjusted in brightness, contrast, and γ settings. Significant difference is indicated: \*\*\*, P \< 0.0001. Bars are in micrometers.](JCB_201309022_Fig4){#fig4}

Hok1 mediates kinesin-3 attachment to the cargo
-----------------------------------------------

We reported previously inhibitory peptides, which interfere with protein--protein interaction in vivo ([@bib55]). We designed an inhibitory peptide pHk^361--385^ covering the region E361 to A385 ([Fig. 4 D](#fig4){ref-type="fig"}, pHk^361--385^). We placed this under the control of strong inducible *crg* promoter ([@bib6]) and expressed it in cells that contain Hok1-GFP-- and mCherry-Rab5a--labeled EEs. After peptide expression for 2 h, both anterograde and retrograde EE motility was lowered significantly ([Fig. 4 G](#fig4){ref-type="fig"}, pHk^361--385^). The motility inhibition was not caused by release of Hok1 from the EEs ([Fig. 4 B](#fig4){ref-type="fig"}, +pHk^361--385^), suggesting that the peptide instead inhibits Hok1 activity. This result confirms a pivotal role for the conserved region within the first CC.

Interestingly, the reduction in EE motility occasionally coincided with formation of EE clusters in subapical cell parts ([Fig. 5, A](#fig5){ref-type="fig"} \[arrowhead\] and B \[asterisk\]; and [Video 7](http://www.jcb.org/cgi/content/full/jcb.201309022/DC1){#supp19}). Here, EE motility is predominantly mediated by kinesin-3 (Fig. S1 B; [@bib56]). We noticed that the anterograde run length of kinesin-3--driven EEs was reduced significantly when the inhibitory peptide was expressed ([Fig. 5, B and C](#fig5){ref-type="fig"}). An extended run length of cargo requires multiple kinesin motors ([@bib35]; [@bib5]), suggesting that inhibition of Hok1 by pHk^361--385^ reduced the number of kinesin-3 on EEs. We tested this by tagging kinesin-3 with GFP and quantifying the number of EE-associated motors, using fluorescent nuclear porins as internal calibration standards. Consistent with [@bib57], we estimated that approximately five kinesin-3 motors (range of 1--18) bind to a single EE in wild-type cells ([Fig. 5, D and E](#fig5){ref-type="fig"}, wild type). In contrast, in the presence of the pHk^361--385^ peptide, the number of EE-attached kinesin-3 motors was reduced significantly (two to three motors; P \< 0.0001; [Fig. 5, D and E](#fig5){ref-type="fig"}, +pHk^361--385^). A similar reduction was found when Hok1^Δ361--385^ was expressed in Δ*hok1* (approximately two motors; [Fig. 5, D and E](#fig5){ref-type="fig"}, Δ*hok1* + Hok1^Δ361--385^), and only one motor was associated with EEs when *hok1* was deleted ([Fig. 5, D and E](#fig5){ref-type="fig"}, Δ*hok1*). These results demonstrate that Hok1, in particular, the conserved region within the CC, participates in attachment of kinesin-3 to EEs. On the other hand, Hok1 still localizes to EEs in the absence of kinesin-3 (Fig. S5 C). Thus, we conclude that Hok1 is an adapter for kinesin-3 cargo attachment. However, the interaction is most likely indirect or transient because immunoprecipitation and mass spectrometry analysis did not reveal a significant interaction between kinesin-3 and Hok1.

![**Hok1 is required for cargo binding of kinesin-3.** (A) Localization of an EE cluster, labeled with GFP-Rab5a (arrowhead) in a cell expressing the peptide pHk^361--385^ for 2 h. Note that clusters initially appear subapically but later shift to the cell end (tip). (B) Motility of GFP-Rab5a--labeled EEs in a cell expressing the peptide pHk^361--385^ for 2 h. A subapical cluster is indicated by an asterisk. Cell end is indicated by tip and the dotted line. See also [Video 7](http://www.jcb.org/cgi/content/full/jcb.201309022/DC1){#supp20}. (C) Mean run length of EEs in control cells and cells expressing pHk^361--385^ for 2 h. Bars represent data from two experiments and are means ± SE; sample size is indicated. Significant difference is indicated: \*\*\*, P \< 0.0001. (D) Contrast-inverted kymographs showing anterograde motility of kinesin-3--GFP in control cells, after expressing the peptide pHk^361--385^, and in Δ*hok1* and Δ*hok1* cells expressing Hok1^Δ361--385^. Kinesin-3 signals are strong in the control but weak in all mutants. (E) Kinesin-3-GFP numbers in control cells, after expressing the peptide pHk^361--385^, and in Δ*hok1--* and *hok1*--null cells expressing Hok^Δ361--385^. Note that native kinesin-3 levels are shown. All numbers represent two experiments and are given as means ± SD; sample size is indicated. Motor number estimation is based on comparison with an internal calibration standard ([@bib57]) and assuming that kinesin-3 is a dimer ([@bib24]). Red dotted lines indicate medians. Images in A, B, and D were adjusted in brightness, contrast, and γ settings. Horizontal bars are in micrometers, and vertical bars are in seconds.](JCB_201309022_Fig5){#fig5}

Kinesin-3 numbers on EEs drop before dynein binding
---------------------------------------------------

Our results indicate that Hok1 mediates attachment of both kinesin-3 and dynein to EEs. In *U. maydis*, retrograde EE motility is driven by single dynein motors, whereas anterograde motility is based on several kinesin-3 motors ([@bib57]). We confirmed this by co-observation of dynein and EEs. We found that 93.6% of all anterograde to retrograde turns within the apical 10 µm of the cell are associated with a retrograde-moving dynein signal (*n* = 44 signals). As these signals represent single dyneins ([Fig. 3 B](#fig3){ref-type="fig"}; [@bib57]; this study), individual dyneins can overcome a "team" of kinesin-3 motors. We reasoned that Hok1 could influence the outcome of a potential tug-of-war by reducing the number of kinesin-3 molecules during dynein attachment and retrograde EE motility. First, we tested whether this is a random process by determining the location where EEs turn from anterograde kinesin-3--driven to retrograde dynein-mediated motility. We focused our analysis on the apical 10 µm of the cell, where MTs are largely unipolar (Fig. S1 B; [@bib56]). We found that most EEs turn at the end of MTs, where dynein is concentrated and interaction between dynein and EEs is increased (Fig. S5 D, bar labeled MT ends; [@bib40]; [@bib55]). However, no preferential turning point was found in these subapical regions (Kruskal--Wallis test, P = 0.6601). This suggests that anterograde to retrograde turning of EEs is a stochastic process. We determined the number of kinesin-3 motors and associated Hok1 proteins on moving EEs and found that on average five kinesin-3 and five Hok1 proteins bind to a single organelle ([Fig. 6 A](#fig6){ref-type="fig"}). This suggests that Hok1 forms a 1:1 complex with kinesin-3, and we considered whether dynein and kinesin-3 compete for an interaction with Hok1. If so, less kinesin-3 would be attached to the EEs during retrograde dynein-driven motility. We did not find such a difference ([Fig. 6 B](#fig6){ref-type="fig"}). This makes a simple competition between dynein and kinesin-3 for binding to Hok1 or its associated adapters unlikely. Alternatively, a Hok1-related mechanism may transiently lower kinesin-3 attachment before dynein binding, thereby modulating the tug-of-war. We investigated this by tracing the binding of dynein to EEs in cells expressing mCherry-Rab5a and GFP fluorescent dynein heavy chain. We observed that anterograde to retrograde turning of EEs is accompanied by a pause in motility that lasted for ∼300 ms ([Fig. 6, C and D](#fig6){ref-type="fig"}). This suggested a "battle" between motors in a presumed tug-of-war. However, dynein did not pause when binding to an EE ([Fig. 6 C](#fig6){ref-type="fig"}) but transported the organelles immediately toward the minus ends of MTs ([Fig. 6 D](#fig6){ref-type="fig"}). This suggests that anterograde kinesin-3 activity is reduced before dynein binds to EEs. We therefore investigated whether release of Hok1-GFP and/or kinesin-3--GFP induces organelle pausing. We found that Hok1-GFP signals remained equal in intensity during anterograde motility, during pausing, and during subsequent retrograde motion ([Fig. 6, E and F](#fig6){ref-type="fig"}, Hok1). In contrast, kinesin-3 GFP fluorescence intensity reduced significantly before pausing of EEs but recovered during retrograde dynein-driven motility ([Fig. 6, E](#fig6){ref-type="fig"} \[Kin3, drop shown by arrowheads\] and F). This suggests that the Hok1 complex releases kinesin-3 before dynein binding, thereby favoring dynein-driven retrograde motion over kinesin-3 in a tug-of-war.

![**Kinesin-3 numbers drop before anterograde to retrograde turning of EEs.** (A) Numbers of Hok1-GFP and kinesin-3--GFP in signals moving bidirectionally. Bars are means ± SE of two experiments; sample size is indicated. No significant difference is found, P = 0.391. Numbers were estimated using an internal calibration standard ([@bib57]) and assume proteins are dimers ([@bib83]; [@bib24]). (B) Numbers of kinesin-3--GFP in anterograde and retrograde signals. Bars are means ± SE of two experiments; sample size is indicated. No significant difference is found, P = 0.811. Numbers were estimated using an internal calibration standard ([@bib57]) and assume proteins are dimers ([@bib24]). (C) Pausing time of EEs and dynein before retrograde motility. Bars are means ± SE of two experiments; sample size is indicated. (D) Kymographs showing the binding of GFP~3~-dynein (green) to a mCherry-Rab5a--labeled EE (red). An anterograde (antero)-moving organelle pauses (pause) before it binds dynein and turns to retrograde motility (retro). (E) False-colored kymographs showing Hok1-GFP and kinesin-3-GFP during anterograde to retrograde turning. Kinesin-3 signals drop just before the organelle pauses (arrowheads). Recovery of the fluorescent signal begins during pause (yellow arrowhead). Note signal variations caused by changes in focal plane and that stationary signals are brighter as they are more focused. (F) Mean intensities of Hok1-GFP and kinesin-3-GFP during anterograde to retrograde turning of EEs. Hok1 numbers remain stable, whereas kinesin-3 signals drop before the pausing phase. Data points are means ± SE from a representative experiment, and sample sizes are indicated. Significant difference is indicated: \*, P \< 0.05; \*\*\*, P \< 0.0001. Images in D and E were adjusted in brightness, contrast, and γ settings. Horizontal bars are in micrometers, and vertical bars are in seconds.](JCB_201309022_Fig6){#fig6}

Controlling motor to cargo attachment by Hook proteins may be conserved
-----------------------------------------------------------------------

The central part of the CC domain shows high amino acid sequence identity with Hook3 ([Fig. 4 D](#fig4){ref-type="fig"}), suggesting that its role in controlling kinesin-3 recruitment may be evolutionarily ancient. We searched publicly available genome data for Hook and kinesin-3. We found Hook proteins, characterized by a Hook domain in the Pfam server (P \< 1.9 × 10^−16^), and kinesin-3 motors, characterized by a Kif1A-like motor domain and a C-terminal DUF3694 and/or pleckstrin homology (PH) domain, in all opisthokonts ([Fig. 7 A](#fig7){ref-type="fig"}), which include animals, fungi, and choanoflagellate protozoa ([@bib63]). Hook appears absent from plants, except barley, and is present in the oomycete *Albugo laibachii*, which is closely related to brown algae ([@bib4]). However, plants do not carry kinesin-3, suggesting that barley may have acquired Hook by horizontal gene transfer. Interestingly, both Hook and kinesin-3 are absent from the Saccharomycotina (*Candida albicans, Saccharomyces cerevisiae*, and *Ashbya gossypii*) and *Schizosaccharomyces pombe*, arguing that this group has lost the machinery for long-range MT-dependent motility during evolution. Collectively, these results suggest that Hook proteins are the universal cargo adapter of kinesin-3.

![**The function of Hok1 is conserved.** (A) Phylogenetic tree of Hook and closest non-Hook proteins and the correlation with the presence of kinesin-3 motors. No Kif1A-like sequence was found at NCBI for *A. fumingatus*, and no Hook was listed for *A. nidulans.* The tree is based on Hook domains, identified in Pfam, and calculated in MEGA 5.10 ([@bib69]). (B) Domain organization of human Hook3 and the chimeric proteins Hok1^HsH3_1--600^, Hok1^HsH3_166--436^, and Hok1^HsH3_293--345^. (C) Colocalization of Hok1^HsH3_1--600^ and Hok1^HsH3_166--436^ with mCherry-Rab5a on apical EEs. (D) Morphology of Δ*hok1* expressing Hok1, Hok1^HsH3_1--600^, Hok1^HsH3_166--436^, and Hok1^HsH3_293--345^. The conserved region of human Hook3 restores the mutant phenotype in *U. maydis*. (E) Co-motility of Hok1^HsH3_293--345^ and mCherry-Rab5a--labeled EEs. See also [Video 8](http://www.jcb.org/cgi/content/full/jcb.201309022/DC1){#supp21}. (F) Bidirectional flux of EEs in wild type and Δ*hok1* expressing Hok1^HsH3_293--345^. Bars represent two experiments and are means ± SE; sample size is indicated. No significant difference was found (P = 0.285, Kruskal--Wallis test). (G) Endocytic sorting defect in Δ*hok1* and dynein (Dyn2^ts^) mutants treated with the dye FM4-64. In wild type, the dye appears in the vacuoles (stained with Cell Tracker Blue CMAC), whereas in the mutants, it accumulates next to GFP-Rab5a--carrying EEs and does not reach the vacuoles (asterisks). The arrowhead indicates the FM4-64--stained "cloud." (H) The late endocytic compartment in Δ*hok1.* In wild-type cells, the late endosomes marker Rab7 localizes to vacuoles and motile structures (arrowhead). In Δ*hok1*, Rab7 colocalizes with the apical FM4-64--positive cloud, whereas the localization on vacuoles is not affected. Images in C, D, E, G, and H were adjusted in brightness, contrast, and γ settings. Horizontal bars are in micrometers, and the vertical bar is in seconds.](JCB_201309022_Fig7){#fig7}

As Hook proteins are present in both fungi and humans, we tested for functional conservation. Hook3 shows high sequence similarities within the functionally important conserved CC stretch, and we therefore set out to restore EE motility in Δ*hok1* mutants by expressing human Hook3 mutant proteins. In humans, Hook3 localizes to Golgi ([@bib77]). To target proteins to EEs, we fused the N-terminal 600 aa of Hook3 to the C-terminal part of Hok1 (Hok1^HsH3_1--600^; [Fig. 7 B](#fig7){ref-type="fig"}) and expressed it in Δ*hok1* mutants. The chimeric protein was correctly targeted to EEs ([Fig. 7 C](#fig7){ref-type="fig"}) but did not rescue the Δ*hok1* phenotype ([Fig. 7 D](#fig7){ref-type="fig"}). We therefore integrated the entire CC region (Hok1^HsH3_166--436^) and the central conserved stretch (aa 293--345; Hok1^HsH3_293--345^) of human Hook3 into Hok1 ([Fig. 7 B](#fig7){ref-type="fig"}). Both proteins targeted correctly ([Fig. 7 C](#fig7){ref-type="fig"}), but only Hok1^HsH3_293--345^ was able to restore EE motility and hyphal growth of Δ*hok1* mutants ([Fig. 7, D--F](#fig7){ref-type="fig"}; and [Video 8](http://www.jcb.org/cgi/content/full/jcb.201309022/DC1){#supp22}). We conclude that the conserved region within the N-terminal CC is most likely involved in regulation of motor--cargo interactions, which may be a conserved function of Hook proteins from fungi to humans.

In *D. melanogaster*, Hook is implied in late endocytic sorting to lysosomes ([@bib37]; [@bib67]). To test whether Δ*hok1* mutants show a similar phenotype, we used the lipophilic styryl dye FM4-64 ([@bib76]), which enters the fungal vacuole/lysosome via endocytic sorting ([@bib17]; [@bib78]). Indeed, FM4-64 appeared in the vacuoles of wild-type cells within 30 min, but no dye was found in EEs or other compartments ([Fig. 7 G](#fig7){ref-type="fig"}, wild type). In contrast, in Δ*hok1*, FM4-64 did not reach the vacuole ([Fig. 7 G](#fig7){ref-type="fig"}, Δ*hok1*, vacuoles indicated by asterisks) and accumulated near the apical cluster of EEs ([Fig. 7 G](#fig7){ref-type="fig"}, Δ*hok1*, arrowhead). To test whether FM4-64--positive "clouds" are part of the late endosomal compartment, we introduced the late endosomal marker GFP-Rab7 ([@bib26]) into Δ*hok1*. In wild type, GFP-Rab7 localized to vacuoles and associated structures that are most likely late endosomes ([Fig. 7 H](#fig7){ref-type="fig"}, wild type). In Δ*hok1* mutants, GFP-Rab7 colocalized with the FM4-64 cloud ([Fig. 7 H](#fig7){ref-type="fig"}, Δ*hok1*), suggesting that Hok1 is required for organization of the late endosomal compartment. Interestingly, a similar FM4-64 distribution defect was found in EE motility--defective dynein mutants ([Fig. 7 G](#fig7){ref-type="fig"}, Dyn2^ts^). These results suggest that Hook-mediated EE motility is essential for endocytic sorting to the vacuole/lysosome compartment. This is consistent with the described role of Hook in late endocytic sorting in *D. melanogaster* ([@bib67]).

Discussion
==========

Here, we report identification of the fungal Hook protein Hok1 as part of an adapter complex that coordinates attachment of dynein and kinesin-3. Hook proteins are known to be involved in endocytic protein trafficking, Golgi organization, and cilium formation ([@bib37], [@bib38]; [@bib67]; [@bib77]; [@bib22]; [@bib3]; [@bib46]), suggesting that they play fundamental roles in eukaryotic cells. Hook proteins bind simultaneously to MTs and organelles and were therefore implicated in the linkage of cargo to cytoskeleton ([@bib77]; [@bib45]; [@bib3]). We demonstrate that Hok1 localizes on rapidly moving organelles, where it mediates dynein and kinesin-3 attachment to EEs. This suggests a more dynamic role for Hook proteins in eukaryotic cells. It was previously noted that the loss of Hook resembles a defect in dynein function ([@bib77]; [@bib68]). Furthermore, Hook from worms links the nucleus to the dynein complex ([@bib47]). Thus, it is possible that Hook proteins are conserved adapters for kinesin-3 and dynein on organelles. This notion is supported by our findings that Hook and kinesin-3 are paired and conserved across the opisthokonts and that Hook mutants in *U. maydis* and *D. melanogaster* share a late endocytic sorting defect ([@bib67]; this study). We also found that a chimeric protein of Hok1 and human Hook3 is functional in *U. maydis*, suggesting that the core function in motor coordination is conserved. However, only the conserved CC stretch of human Hook3 was functional when integrated into Hok1, whereas several other Hok1-Hook3 chimeric proteins failed to rescue the Δ*hok1* phenotype. Therefore, we consider it likely that the detailed mechanism of Hook function is different between fungi and humans.

A key question is how Hok1 performs its role in regulating EE motility. Our data suggest that the role of Hook proteins in motor coordination may be conserved. We therefore set out to interpret our results in the context of a published study on the function of animal Hook proteins ([@bib83]). We report that Hok1 is a central part of a larger protein complex that includes FTS and FHIP homologues Fts1 and Fhp1. In humans, both proteins interact with a conserved part of the C-terminal domain of Hook proteins ([@bib83]). Fts1 and Fhp1 bind more strongly to Hok^225--930^ but only weakly to Hok1^625--930^. Thus, binding to Hok1 requires both the C-terminal region and the CC domain. This suggests that FHIP and FTS bridge between both domains ([Fig. 8](#fig8){ref-type="fig"}, inset a). The function of both proteins is currently not known, but their ability to bind to the EE-targeting C terminus of Hok1 raises the possibility that Fts1 and Fhp1 participate in anchoring the Hok1 adapter complex to EEs.

![**Model of Hok1 in controlling EE motility.** (A) Fts1, Fhp1, and Hok1 form a complex that may contain additional, yet unknown, adapter proteins that link dynein and kinesin-3 to this Hok1 complex (b and c). Kinesin-3 binds to Hok1 and, to a lesser extent, directly to EE membranes. (B) Before dynein binding, the Hok1 complex releases kinesin-3. The cargo stops moving but remains attached to the MT. This may reflect the ability of Hok1 to bind MTs, as described for human Hook proteins ([@bib77]). (C) Dynein leaves the MT plus ends and travels toward the pausing EE, where it interacts with the Hok1 complex. This could involve the dynactin complex, as shown in the fungus *A. nidulans* (c; [@bib84]). (D and E) During pausing and while dynein moves the cargo to minus ends of MTs, kinesin-3 rebinds to the Hok1 complex. Speculative parts of the model are indicated by question marks.](JCB_201309022_Fig8){#fig8}

Surprisingly, we did not find an interaction of Hok1 with dynein or kinesin-3 when precipitating Hok1 from cell extracts. This suggests that transient interaction only occurs on EE membranes. Additional adapter proteins may bridge between the N-terminal region of Hok1, which we show here is essential for motor binding and kinesin-3 and dynein ([Fig. 8](#fig8){ref-type="fig"}, inset a). In humans, the HAP1 binds to kinesin-1 and the dynactin subunit p150^Glued^ ([@bib16]; [@bib44]; [@bib48]) and links them to the disease protein huntingtin to enable coordination of intracellular membrane trafficking ([@bib9]). Our results suggest that a similar adapter could link Hok1 and kinesin-3/dynein. The DENN/MADD protein binds to the stalk of the mammalian kinesin-3 motors Kif1a and Kif1B and links them to synaptic vesicles via the small GTPase Rab3 ([@bib52]). However, we did not find a homologue of DENN/MADD in the genome of *U. maydis*. Therefore, a similar link to Rab-GTPases and Hok1 is unlikely. We conject that an unknown Hok1-interacting adapter needs to be identified ([Fig. 8](#fig8){ref-type="fig"}, inset a). Our immunoprecipitation experiments only identified Fts1 and Fhp1 as Hok1 interactors, raising the possibility that these proteins participate in the binding of Hok1 to motors. Further studies are needed to address this question.

We found that ∼20% of kinesin-3 remained bound to EEs in the absence of Hok1. This suggests an additional, Hok1-independent way of interacting with the cargo. It was shown that the C-terminal PH domain of ameba kinesin-3 directly binds phosphatidylinositol (4,5) bisphosphate ([@bib34]). *U. maydis* Kin3 contains a conserved PH domain ([@bib80]), suggesting that the motor can bind to EE membranes independently of the Hok1 complex. As this membrane-bound kinesin-3 is active, it ultimately drives EEs to plus ends in Δ*hok1* mutants. However, the reduced number of kinesin-3 on EE results in a decrease in run length. This corresponds well with findings that extended run length of cargo depends on multiple kinesin motors ([@bib35]; [@bib5]; [@bib15]; [@bib54]). We therefore conclude that the Hok1 adapter complex increases the motor number on organelles, thereby enabling extended runs of up to 90 µm ([@bib56]). We reported recently that this extended motility is required to distribute ribosomes and mRNA efficiently in the elongated hyphal cells ([@bib26]).

Our results suggest that the same number of kinesin-3 and Hok1 resides on anterograde-moving EEs ([Fig. 8 B](#fig8){ref-type="fig"}). A change in transport direction is initiated by the release of kinesin-3 from the Hok1 adapter, which itself stays on the EEs. The trigger for this event is unknown, but we find no preference for turning of the transport direction along the apical MTs. Thus, we consider it likely that the release of kinesin-3 is a stochastic event. This does not exclude the possibility that higher order control via phosphorylation/dephosphorylation could participate in the release of kinesin-3. Indeed, phosphorylation of huntingtin recruits kinesin-1 to cargo vesicles, which results in a longer anterograde run length of vesicles ([@bib10]). A similar mechanism was reported for coordinated bidirectional transport of amyloid precursor protein in axons. Here, phosphorylation of the kinesin-1-- and dynactin-binding scaffold protein JIP1 enhances the association of kinesin-1, thereby supporting anterograde motility. In contrast, dephosphorylation releases kinesin-1 and most likely fosters binding of dynein--dynactin ([@bib19]). Although it is tempting to speculate that kinesin-3 is released from the EEs upon dephosphorylation of a Hok1-interacting adapter, experimental evidence for such a mechanism is currently missing.

The release of kinesin-3 reduces anterograde forces and results in a pause of EE motility. Surprisingly, we found that these pausing EEs do not diffuse away from the MT. This suggests that they are anchored to the track. Whether Hok1 is involved in this anchorage is unknown, but human Hook is able to bind MTs ([@bib77]). Although we did not find strong association of Hok1 with MTs, the protein may mediate transient interaction of EEs with MTs ([Fig. 8 B](#fig8){ref-type="fig"}). Subsequently, dynein binds to the pausing organelles ([Fig. 8, C and D](#fig8){ref-type="fig"}). This situation is most likely specific for *U. maydis*, in which dynein is released from the MT plus ends and binds to EEs during retrograde movements, whereas anterograde EEs do not carry dynein ([@bib57]). We suggest that a conformational change in the Hok1 adapter complex releases Kin3. This may allow efficient interaction of dynein--dynactin with the adapter complex. Currently, we do not know which part of the dynein--dynactin complex binds to the Hok1 adapter. In *Aspergillus nidulans*, the dynactin complex component p25 is required for EE motility ([Fig. 8, D and E](#fig8){ref-type="fig"}, insets c and d; [@bib84]). However, in mammalian cells, the intermediate chains of dynein interact with an unknown factor on signaling endosomes ([@bib50]), which might resemble a Hook adapter. It remains to be shown whether Hook proteins control mammalian endosome motility.

Finally, we show that kinesin-3 returns to the EEs, whereas dynein takes the cargo toward MT minus ends. We found five kinesin-3 motors on retrograde-moving EEs, but these are not taking over. How this is achieved remains obscure, but one possibility is that during retrograde motility, kinesin-3 is bound in an inactive state. Indeed, a retrograde to anterograde turn in transport is always associated with the release of dynein, but in most cases, these organelles pause before returning to anterograde motility ([@bib57]). This suggests that kinesin-3 does not force the turning. In other words, the release of dynein and the switch to anterograde motility are most likely not simple consequences of a tug-of-war. Instead, kinesin-3 appears to need the pause time to take over, which could reflect activation after dynein release. The mechanism by which dynein releases and kinesin-3 is activated may involve Hok1-associated proteins and will be subject to future investigations.

Conclusion
----------

In this study, we show that Hok1 mediates both dynein and kinesin-3 recruitment to EEs and thus regulates bidirectional EE motility. We provide evidence that the core role in controlling motor attachment is conserved and show that the pairing of Hook and kinesin-3 is conserved across the opisthokonts. Thus, we propose that Hook proteins are most likely general regulatory adapters for kinesin-3 and dynein in cargo transport in eukaryotes. Although our work establishes this novel role of Hook proteins, it also opens up numerous new questions. Among these are (a) what are the adapters that bridge between Hook and the motors, (b) how does the Hok1 complex "know" when to release kinesin-3, (c) what is the role of FTS and FHIP in the adapter complex, and (d) how is the activity status of kinesin-3 regulated? More research on the Hok1-interacting proteins might shed light on these questions. However, the identification of Hook as a coordinator of kinesin-3 and dynein activity opens new avenues to better understanding membrane trafficking in eukaryotic cells.

Materials and methods
=====================

Growth conditions
-----------------

All cultures of *U. maydis* were grown for 8--15 h at 28°C in a complete medium ([@bib30]) containing 1% (wt/vol) glucose, shaking at 200 rpm. Hyphal growth was induced overnight by shifting to nitrate minimal (NM) medium supplemented with 1% (wt/vol) glucose ([@bib7]). To induce expression of the pHk^361--385^ peptide under the *crg* promoter ([@bib6]), cells were grown in NM liquid medium containing 1% (wt/vol) arabinose for 2 h ([@bib7]). The temperature-sensitive mutant strain AB5Dyn2^ts^\_GRab5a was grown at 22°C and was shifted to restrictive conditions (32°C) for 2 h to perform the FM4-64 experiment or overnight to assess EE distribution and motility.

Strains and plasmids
--------------------

*U. maydis* strains and plasmids used in this study are summarized in [Table 1](#tbl1){ref-type="table"}, and their usage throughout the study is summarized in [Table S1](http://www.jcb.org/cgi/content/full/jcb.201309022/DC1){#supp23}. Recombinant DNA was introduced into *U. maydis* by homologous recombination. All plasmids were generated using standard techniques and in vivo recombination in *S. cerevisiae* using strains DS94 (MATα *ura3-52 trp1-1 leu2-3 his3-111 lys2-801*; [@bib70]) and FY834 (*MATα his3 Δ200 ura3-52 leu2Δ1 lys2Δ202 trp1Δ63;* [@bib82]) and following published protocols ([@bib36]; [@bib53]).

###### 

Strains and plasmids used in this study

  Strain name                              Genotype                                                                                            Source
  ---------------------------------------- --------------------------------------------------------------------------------------------------- ------------
  AB33                                     *a2 PnarbW2 PnarbE1*, *ble*^R^                                                                      [@bib7]
  EMD5 (AB33_GRab5a)                       *a2 PnarbW2 PnarbE1*, *ble*^R^/pCoGRab5a                                                            This study
  AB33ΔKin3                                *a2 PnarbW2 PnarbE1*, *ble*^R^, *Δkin3*, *nat*^R^                                                   [@bib26]
  AB33ΔKin3_GRab5a                         *a2 PnarbW2 PnarbE1*, *ble*^R^, *Δkin3*, *nat*^R^/pCoGRab5a                                         [@bib56]
  AB5Dyn2^ts^\_GRab5a                      *a2 PnarbW2 PnarbE1*, *ble*^R^, P*dyn2-dyn2ts*, *hyg*^R^/pCoGRab5a                                  [@bib56]
  AB33GRab5a                               *a2 PnarbW2 PnarbE1*, *ble*^R^/po^N^GRab5a                                                          [@bib55]
  AB33ΔHok1                                *a2 PnarbW2 PnarbE1*, *ble*^R^, *Δhok1*, *hyg*^R^                                                   This study
  AB33ΔHok1_Hok1                           *a2 PnarbW2 PnarbE1*, *ble*^R^, *Δhok1*, *hyg*^R^/p^C^Hok1G                                         This study
  EMD5_Hok1                                *a2 PnarbW2 PnarbE1*, *ble*^R^/pCoGRab5a/pHok1_SE                                                   This study
  AB33GRab5a_ΔHok1                         *a2 PnarbW2 PnarbE1*, *ble*^R^, *Δhok1*, *hyg*^R^/po^N^GRab5a                                       This study
  AB33_mChRab5a_Hok1G                      *a2 PnarbW2 PnarbE1*, *ble*^R^, P*hok1-hok1-egfp*, *hyg*^R^/po~m~ChRab5a                            This study
  AB33ΔHok1_mChRab5a                       *a2 PnarbW2 PnarbE1*, *ble*^R^, *Δhok1*, *hyg*^R^/po~m~ChRab5a                                      This study
  AB33ΔHok1_mChRab5a_Hok1^625--930^G       *a2 PnarbW2 PnarbE1*, *ble*^R^, *Δhok1*, *hyg*^R^/po~m~ChRab5a/pHok1^625--930^G                     This study
  AB33_mChTub1_Hok1^1--224^G               *a2 PnarbW2 PnarbE1*, *ble*^R^/pHo~m~ChTub1/pHok1^1--224^G                                          This study
  AB33ΔHok1_mChRab5a_Hok1^225--930^G       *a2 PnarbW2 PnarbE1*, *ble*^R^, *Δhok1*, *hyg*^R^/po~m~ChRab5a/pHok1^225--930^G                     This study
  AB33ΔHok1_mChRab5a_Hok1^1--224^G         *a2 PnarbW2 PnarbE1*, *ble*^R^, *Δhok1*, *hyg*^R^/po~m~ChRab5a/pHok1^1--224^G                       This study
  AB33ΔHok1_mChRab5a_Hok1^225--624^G       *a2 PnarbW2 PnarbE1*, *ble*^R^, *Δhok1*, *hyg*^R^/po~m~ChRab5a/pHok1^225--624^G                     This study
  AB33ΔHok1_mChRab5a_Hok1^1--624^G         *a2 PnarbW2 PnarbE1*, *ble*^R^, *Δhok1*, *hyg*^R^/po~m~ChRab5a/pHok1^1--624^G                       This study
  AB33ΔHok1_mChRab5a_Hok1^1--624^PXG       *a2 PnarbW2 PnarbE1*, *ble*^R^, *Δhok1*, *hyg*^R^/po~m~ChRab5a/pHok1^1--624^PXG                     This study
  AB33G~3~Dyn2                             *a2 PnarbW2 PnarbE1*, *ble*^R^, P*dyn2-3gfp-dyn2*, *nat*^R^                                         This study
  AB33G~3~Dyn2_ΔHok1                       *a2 PnarbW2 PnarbE1*, *ble*^R^, P*dyn2-3gfp-dyn2*, *nat*^R^, *Δhok1*, *hyg*^R^                      This study
  AB33G~3~Dyn2_ΔHok1_mChRab5a              *a2 PnarbW2 PnarbE1*, *ble*^R^, P*dyn2-3gfp-dyn2*, *nat*^R^, *Δhok1*, *hyg*^R^/po^C^~m~ChRab5a      This study
  AB33mCh~3~Dyn2_ΔHok1_Hok1^1--624^G       *a2 PnarbW2 PnarbE1*, *ble*^R^, P*dyn2-3mcherry-dyn2*, *nat*^R^, *Δhok1*, *hyg*^R^/pHok1^1--624^G   This study
  AB33ΔHok1_mChRab5a_Hok1^Δ225--624^G      *a2 PnarbW2 PnarbE1*, *ble*^R^, *Δhok1*, *hyg*^R^/po~m~ChRab5a/pHok1^Δ225--624^G                    This study
  AB33ΔHok1_mChRab5a_Hok1^1--224^PXG       *a2 PnarbW2 PnarbE1*, *ble*^R^, *Δhok1*, *hyg*^R^/po~m~ChRab5a/pHok1^1--224^PXG                     This study
  AB33_mChRab5a_Hok1G\_↑pHk^361--385^      *a2 PnarbW2 PnarbE1*, *ble*^R^, P*hok1-hok1-egfp*, *hyg*^R^/po~m~ChRab5a/pHk^361--385^              This study
  AB33ΔHok1_mChRab5a_Hok1^Δ361--385^G      *a2 PnarbW2 PnarbE1*, *ble*^R^, *Δhok1*, *hyg*^R^/po~m~ChRab5a/pHok1^Δ361--385^G                    This study
  AB33ΔHok1_mChRab5a_Hok1^Δ333--355^G      *a2 PnarbW2 PnarbE1*, *ble*^R^, *Δhok1*, *hyg*^R^/po~m~ChRab5a/pHok1^Δ333--355^G                    This study
  AB33GRab5a\_↑pHk^361--385^               *a2 PnarbW2 PnarbE1*, *ble*^R^/po^N^GRab5a/pHk^361--385^                                            This study
  AB33Kin3G                                *a2 PnarbW2 PnarbE1*, *ble*^R^, P*kin3-kin3-egfp*, *hyg*^R^                                         [@bib56]
  AB33Kin3G_ΔHok1                          *a2 PnarbW2 PnarbE1*, *ble*^R^, P*kin3-kin3-egfp*, *hyg*^R^, *Δhok1*, *nat*^R^                      This study
  AB33Kin3G\_↑pHk^361--385^                *a2 PnarbW2 PnarbE1*, *ble*^R^, P*kin3-kin3-egfp*, *hyg*^R^/pHk^361--385^                           This study
  AB33Kin3G_ΔHok1_Hok1^Δ361--385^          *a2 PnarbW2 PnarbE1*, *ble*^R^, P*kin3-kin3-egfp*, *hyg*^R^, *Δhok1*, *nat*^R^/pHok1^Δ361--385^HA   This study
  AB33G~3~Dyn2_mChRab5a                    *a2 PnarbW2 PnarbE1*, *ble*^R^, P*dyn2-3gfp-dyn2*, *nat*^R^/po~m~ChRab5a                            [@bib57]
  AB33ΔHok1_mChRab5a_pHok1^H3_1--600^G     *a2 PnarbW2 PnarbE1*, *ble*^R^, *Δhok1*, *hyg*^R^/po~m~ChRab5a/pHok1^H3_1--600^G                    This study
  AB33ΔHok1_mChRab5a_pHok1^H3_166--436^G   *a2 PnarbW2 PnarbE1*, *ble*^R^, *Δhok1*, *hyg*^R^/po~m~ChRab5a/pHok1^H3_166--436^G                  This study
  AB33ΔHok1_mChRab5a_pHok1^H3_293--345^G   *a2 PnarbW2 PnarbE1*, *ble*^R^, *Δhok1*, *hyg*^R^/po~m~ChRab5a/pHok1^H3_293--345^G                  This study
  AB33_mChRab5a_Fts1G                      *a2 PnarbW2 PnarbE1*, *ble*^R^, P*fts1-fts1-egfp*, *hyg*^R^/po~m~ChRab5a                            This study
  AB33_mChRab5a_Fhp1G                      *a2 PnarbW2 PnarbE1*, *ble*^R^, P*fhp1-fhp1-egfp*, *hyg*^R^/po~m~ChRab5a                            This study
  AB33_mChRab5a_Hok1G_ΔKin3                *a2 PnarbW2 PnarbE1*, *ble*^R^, P*hok1-hok1-egfp*, *hyg*^R^, *Δkin3*, *cbx*^R^/po~m~ChRab5a         This study
  AB33GRab7                                *a2 PnarbW2 PnarbE1*, *ble*^R^/poGRab7                                                              [@bib26]
  AB33ΔHok1_GRab7                          *a2 PnarbW2 PnarbE1*, *ble*^R^, *Δhok1*, *hyg*^R^/poGRab7                                           This study
  AB33nRFP                                 *a2 PnarbW2 PnarbE1*, *ble*^R^/poNLS3RFP                                                            [@bib55]
  FB2N107G                                 *a2b2* P*nup107-nup107-egfp*, *ble*^R^                                                              [@bib66]
  pCoGRab5a                                P*otef-egfp-rab5a*, *cbx*^R^                                                                        [@bib26]
  pΔKin3                                   *Δkin3*, *nat*^R^                                                                                   [@bib57]
  po^N^GRab5a                              P*otef-egfp-rab5a*, *nat*^R^                                                                        [@bib55]
  p^H^ΔHok1                                *Δhok1*, *hyg*^R^                                                                                   This study
  pHok1_SE                                 P*hok1-hok1*, *SE*, *hyg*^R^                                                                        This study
  p^C^Hok1G                                P*hok1-hok1-egfp*, *cbx*^R^                                                                         This study
  po~m~ChRab5a                             P*otef-mcherry-rab5a*, *nat*^R^                                                                     [@bib58]
  pHok1G                                   P*hok1-hok1-3egfp*, *hyg*^R^                                                                        This study
  pHok1^625--930^G                         P*hok1-hok1^625--930^-egfp*, *cbx*^R^                                                               This study
  pHok1^225--930^G                         P*hok1-hok1^225--930^-egfp*, *cbx*^R^                                                               This study
  pHok1^1--224^G                           P*hok1-hok1^1--224^-egfp*, *cbx*^R^                                                                 This study
  pHok1^225--624^G                         P*hok1-hok1^225--624^-egfp*, *cbx*^R^                                                               This study
  pHok1^1--624^G                           P*hok1-hok1^1--624^-egfp*, *cbx*^R^                                                                 This study
  pHok1^1--624^PXG                         P*hok1-hok1^1--624^-yup1^4--148^-egfp*, *cbx*^R^                                                    This study
  pHo~m~ChTub1                             P*otef-mCherry-tub1*, *hyg*^R^                                                                      [@bib58]
  p^N^G~3~Dyn2                             P*dyn2-3gfp-dyn2*, *nat*^R^                                                                         This study
  po^C^~m~ChRab5a                          P*otef-mcherry-rab5a*, *cbx*^R^                                                                     This study
  pHok1^Δ225--624^G                        P*hok1-hok1^Δ225--624^-egfp*, *cbx*^R^                                                              This study
  pHok1^1--224^PXG                         P*hok1-hok1^1--224^-yup1^4--148^-egfp*, *cbx*^R^                                                    This study
  pHk^361--385^                            P*crg-hok1^361--385^*, *cbx*^R^                                                                     This study
  pHok1^Δ361--385^G                        P*hok1-hok1^Δ361--385^-egfp*, *cbx*^R^                                                              This study
  pHok1^Δ333--355^G                        P*hok1-hok1^Δ333--355^-egfp*, *cbx*^R^                                                              This study
  pHok1^Δ361--385^HA                       P*hok1-hok1^Δ361--385^-HA*, *cbx*^R^                                                                This study
  pHok1^H3_1--600^G                        P*hok1-hshook3^1--600^-hok1^625--930^-egfp*, *cbx*^R^                                               This study
  pHok1^H3_166--436^G                      P*hok1-hok1^1--224^-hshook3^166--436^-hok1^625--930^-egfp*, *cbx*^R^                                This study
  pHok1^H3_293--345^G                      P*hok1-hok1^1--332^-hshook3^293--345^-hok1^386--930^-egfp*, *cbx*^R^                                This study
  pKin3G_H                                 P*kin3-kin3-egfp*, *hyg*^R^                                                                         [@bib57]
  p^N^ΔHok1                                *Δhok1*, *nat*^R^                                                                                   This study
  pFts1G                                   P*fts1-fts1-egfp*, *hyg*^R^                                                                         This study
  pFhp1G                                   P*fhp1-fhp1-egfp*, *hyg*^R^                                                                         This study
  p^C^ΔKin3                                *Δkin3*, *cbx*^R^                                                                                   This study
  poGRab7                                  P*otef-egfp-rab7*, *cbx*^R^                                                                         [@bib26]
  pN107G                                   P*nup107-nup107-egfp*, *ble*^R^                                                                     [@bib71]

*a* and *b*, mating type loci; *P*, promoter; a hyphen indicates fusion; *Δ*, deletion; a slash indicates ectopically integrated; *hyg*^R^, hygromycin resistance; *ble*^R^, phleomycin resistance; *nat*^R^, nourseothricin resistance; *cbx*^R^, carboxin resistance; *ts*, temperature-sensitive allele; *crg*, conditional arabinose-induced promoter; *otef*, constitutive promoter; *nar*, conditional nitrate reductase promoter; *E1* and *W2*, genes of the *b* mating type locus; *SE*, self-replicating plasmid; *mCherry*, monomeric Cherry; *kin3*, kinesin-3; *dyn2*, C-terminal half of the dynein heavy chain; *tub1*, tubulin α; *nup107*, nucleoporin; PX, PX domain from the putative endosomal t-SNARE Yup1; *rab5a* and *rab7*, small endosomal GTPases; HA, human influenza HA tag; *hok1*, Hook protein in *U. maydis*; *hshook3*, Hook3 from human; *fts1*, FTS homologue; *fhp1*, FHIP homologue.

The plasmid pCoGRab5a ([@bib26]), which contains the carboxin resistance cassette and *rab5a* gene fused to EGFP under the *potef* promoter ([@bib61]), was linearized and integrated ectopically into strain AB33 ([@bib7]), resulting in AB33_GRab5a, which was used for the UV mutagenesis. To obtain AB33ΔKin3 ([@bib26]), plasmid pΔKin3 ([@bib57]), containing a nourseothricin resistance cassette flanked by the *kin3* promoter and the sequence downstream of the *kin3* gene carried by the pTZ19R vector (Fermentas), was digested with PvuI and integrated into the *kin3* locus of strain AB33 ([@bib7]). Correct integration was confirmed by PCR and by Southern blotting. The strain AB33_mChTub1 was made by ectopic integration of plasmid pHo~m~ChTub1 ([@bib58]) into AB33 ([@bib7]), resulting in AB33_mChTub1. The plasmid pHo~m~ChTub1 contains the hygromycin resistance cassette and *tubulin-α* gene (*tub1*) fused to mCherry under the *potef* promoter ([@bib61]). To obtain the AB33_mChRab5a strain, plasmid po~m~ChRab5a ([@bib57]), which contains the nourseothricin resistance cassette and *rab5a* gene fused to mCherry under the *potef* promoter, was linearized and integrated ectopically into strain AB33. To obtain strain AB33mCh~3~Dyn2, plasmid pDyn2_3mCh ([@bib57]), containing a triple mCherry tag C-terminally fused to a dynein heavy chain gene (*dyn2*), was digested with DraI and HindIII and homologously integrated into AB33 ([@bib7]). Correct integration was confirmed by Southern blotting.

### p^N^G~3~Dyn2.

This plasmid contains the native promoter of the *dyn*2 gene followed by a triple GFP and the first 1,762 bp of the open reading frame of *dyn*2. To integrate into the native locus, a second fragment, containing a part of the promoter and the nourseothricin resistance cassette, was fused in front of the full-length promoter. The plasmid pGFP~3~Dyn2 ([@bib40]) was digested with NotI to remove the hygromycin resistance cassette, which was replaced by the nourseothricin resistance cassette. This plasmid was transformed into strain AB33 ([@bib7]), resulting in strain AB33G~3~Dyn2. Integration of triple GFP into the *dyn2* locus was confirmed by Southern blotting.

### p^H^ΔHok1.

In this plasmid, the endogenous *hok1* gene is replaced by the hygromycin resistance gene; the promoter sequence and a downstream sequence allow this plasmid to integrate into the *hok1* locus, which results in a deletion of the *hok1* open reading frame. To obtain the plasmid p^H^ΔHok1, a 1,077-bp fragment, containing the *hok1* promoter, and a 1,055-bp fragment of genomic DNA, containing the downstream sequence of the *hok1* gene, were amplified by PCR using sets of primers ~f~EB382-~r~EB383 and ~f~EB385-~r~EB384, respectively (primers sequences are summarized in [Table S2](http://www.jcb.org/cgi/content/full/jcb.201309022/DC1){#supp24}). Obtained fragments were cloned by in vivo recombination in the yeast *S. cerevisiae* DS94, flanked by the hygromycin resistance cassette, into a 5,088-bp region of the pNEBcbx-yeast plasmid ([@bib55]), which was digested by EcoRI and HindIII. For transformation into the *U. maydis* strains AB33 ([@bib7]), AB33GRab5a ([@bib55]), AB33G~3~Dyn2, and AB33mCh~3~Dyn2, the plasmid p^H^ΔHok1 was digested with AlwNI and integrated into the *hok1* locus, resulting in AB33ΔHok1, AB33GRab5a_ΔHok1, AB33G~3~Dyn2_ΔHok1, and AB33mCh~3~Dyn2_ΔHok1, respectively. Deletion of the *hok1* gene was confirmed by PCR and Southern blotting. Plasmids po~m~ChRab5a ([@bib57]) and poGRab7 ([@bib26]) were integrated ectopically into the strain AB33ΔHok1, resulting in AB33ΔHok1_mChRab5a and AB33ΔHok1_GRab7, respectively.

### p^N^ΔHok1.

In this plasmid, the endogenous *hok1* gene is replaced by the nourseothricin resistance gene, which is flanked by a native promoter of *hok1* and a downstream sequence of the *hok1* gene region. To obtain the plasmid p^N^ΔHok1, the plasmid p^H^ΔHok1 was digested by HindIII and AflII to remove the hygromycin resistance cassette, and a 1,524-bp region encoding the nourseothricin resistance cassette was cloned into the plasmid using in vivo recombination in *S. cerevisiae* DS94 and primers ~f~EB395-~r~EB396. For transformation into the *U. maydis* AB33Kin3G strain ([@bib56]), the plasmid p^N^ΔHok1 was digested with AlwNI, resulting in AB33Kin3G_ΔHok1. Deletion of the *hok1* gene was confirmed by PCR and Southern blotting.

### pHok1_SE.

This plasmid is able to self-replicate in *U. maydis* and contains the *hok1* promoter (−1,002 bp), the *hok1* gene, and the hygromycin resistance cassette. To generate this plasmid, the self-replicating plasmid pNEBUC-yeast (provided by S. Kilaru, University of Exeter, Exeter, England, UK) was constructed through in vivo recombination in the yeast *S. cerevisiae* DS94. A 2,680-bp fragment, containing the yeast URA3 marker and 2µ *ori*, was amplified from plasmid pEYA2 (Invitrogen) and was cloned into the plasmid pNEBUC, which was linearized by SacI. The resulting plasmid pNEBUC-yeast contained the ampicillin resistance cassette, an *Escherichia coli* origin of replication, a *U. maydis* autonomously replicating sequence, and the carboxin resistance cassette. Next, a 4,859-bp fragment containing the *hok1* promoter and gene was amplified from the genomic DNA of the *U. maydis* strain 521 using sets of primers ~f~AB1-~r~AB8 and cloned into the plasmid pNEBUC-yeast, digested with PvuII and XbaI, using a yeast recombination technique and *S. cerevisiae* strain FY834. Finally, the carboxin resistance cassette was replaced by the hygromycin resistance cassette, obtained as a 2,896-bp fragment from plasmid pGFP~3~Dyn2 ([@bib40]), by digestion of the obtained plasmid pNEBUC-Hok1 with NotI. The plasmid was transformed into EMD5 strain, resulting in EMD5_Hok1 (all strains are listed in [Table 1](#tbl1){ref-type="table"}).

### p^C^Hok1G.

This plasmid contains a *hok1* gene fused to EGFP. The *hok1* gene is located behind the *hok1* promoter (−1,002 bp), and the plasmid contains the carboxin resistance cassette. To obtain the plasmid, first a yeast bacterial shuttle vector that contained a single SspI restriction site within the carboxin resistance cassette was generated in the yeast *S. cerevisiae* DS94. The pNEBcbx-yeast-SspI plasmid was derived from the plasmid pNEBcbx-yeast ([@bib55]), which was linearized by ZraI and modified by replacement of a fragment containing the ZraI site flanked by two SspI sites with a fragment containing one NdeI site amplified from the pKin3G plasmid ([@bib80]), using primers ~f~EB39 and ~r~EB40. This plasmid was next used to obtain the pHok1G plasmid, in which a 1,002-bp region encoding the *hok1* promoter (−1,002 bp) and the *hok1* gene was amplified from genomic DNA of *U. maydis* strain 521, using sets of primers ~f~AB85-~r~AB86 and ~f~AB87-~r~AB88, respectively. A 1,045-bp region encoding EGFP and the *Tnos* terminator was amplified from the plasmid pKin3G ([@bib80]), using primers ~f~AB33-~r~EB14 and was cloned into the pNEBcbx-yeast-SspI plasmid, digested with EcoRI and SacI, by in vivo recombination in the yeast *S. cerevisiae* FY834. The plasmid pHok1G was linearized with SspI and integrated into the succinate dehydrogenase locus of strain AB33ΔHok1, resulting in AB33ΔHok1_Hok1G.

### pHok1G~3~.

The plasmid consists of a 1,003-bp fragment near the 3′ end of the *hok1* gene followed by triple *egfp* and the *Tnos* terminator, the hygromycin resistance cassette, and a 999-bp fragment downstream of the *hok1* gene. The plasmid was generated through in vivo recombination in the yeast *S. cerevisiae* DS94. Fragments 1,003 and 999 bp were amplified with 30-bp overhangs from genomic DNA of the *U. maydis* strain 521 using sets of primers ~f~EB378-~r~EB379 and ~f~EB376-~r~EB377, respectively, and cloned with a 5,271-bp fragment encoding triple EGFP, the *Tnos* terminator, and the hygromycin cassette and a 4,968-bp fragment encoding an ampicillin resistance cassette, an *E. coli* replication origin, the yeast URA3 marker, and 2µ *ori*. Both fragments were derived from the plasmid pGrc1-3G ([@bib56]) by digestion with SacI and MluI (a 5,271-bp fragment) and with PsiI and AgeI (a 4,968-bp fragment). The plasmid pHok1G~3~ was digested with PsiI and BamHI and homologously integrated into the *hok1* locus of strain AB33_mChRab5a, resulting in AB33_mChRab5a_Hok1G. Integration of a single EGFP into the *hok1* locus was confirmed by PCR and Southern blotting.

### pHok1^225--930^G.

This plasmid contains a *hok1* gene, truncated in the N-terminal region (Δ1--224 aa) and fused to EGFP. The *hok1* gene is located behind the *hok1* promoter (−1,002 bp), and the plasmid contains the carboxin resistance cassette. A 1,002-bp region encoding the *hok1* promoter (−1,002 bp) and a region of 225--930 aa were amplified from genomic DNA of *U. maydis* strain 521, using sets of primers ~f~AB85-~r~AB86 and ~f~AB87-~r~AB88, respectively. A 1,045-bp region encoding EGFP and the *Tnos* terminator was amplified from the plasmid pKin3G ([@bib80]), using primers ~f~AB33-~r~EB14, and was cloned into the pNEBcbx-yeast-SspI plasmid, digested with EcoRI and SacI, by in vivo recombination in the yeast *S. cerevisiae* FY834. The plasmid pHok1^225--930^G was linearized with SspI and integrated into the succinate dehydrogenase locus of strain AB33ΔHok1_mChRab5a, resulting in AB33ΔHok1_mChRab5a_Hok1^225--930^G.

### pHok1^625--930^G.

This plasmid contains a *hok1* gene truncated in the N-terminal region and the middle part (Δ1--624 aa), fused to *egfp*. The construct was placed under the *hok1* promoter (−1,002 bp) and contains the carboxin resistance cassette. The plasmid was generated through in vivo recombination in the yeast *S. cerevisiae* FY834. To obtain a backbone with the carboxin resistance cassette and a C-terminal *egfp* gene followed by the *Tnos* terminator, the plasmid pNEB-cbx-yeast-pkin3_kin3^1--369^PX-GFP was digested with NaeI and SexAI producing a fragment of 7,990 bp. The fragments encoding the promoter (−1,002 bp) and a region of 625--930 aa were amplified from the genomic DNA of the *U. maydis* strain 521 using sets of primers ~f~AB85-~r~AB86 and ~f~AB133-~r~AB88, respectively. The plasmid pHok1^625--930^G was digested with SspI and integrated into the succinate dehydrogenase locus of strain AB33ΔHok1_mChRab5a, resulting in AB33ΔHok1_mChRab5a_Hok1^625--930^G.

### pHok1^1--224^G.

This plasmid contains a fragment of the *hok1* gene encoding only the N-terminal region (aa 1--224), fused to EGFP. To obtain the plasmid pHok1^1--224^G, the promoter (−1,002 bp), followed by the first 224 aa of the *hok1* gene, was amplified by PCR, thereby introducing the restrictions sites of KpnI and NcoI. The PCR product was digested with KpnI and NcoI, producing a fragment of 1,669 bp. To obtain the backbone with the carboxin resistance cassette and a C-terminal *egfp* gene, followed by the *Tnos* terminator, the plasmid p123 ([@bib1]) was digested with KpnI and NcoI, producing a fragment of 5,396 bp. After a two fragment ligation, the plasmid pHok1^1--224^G carried the carboxin and ampicillin resistance cassettes, an *E. coli* replication origin, the native promoter of the *hok1* gene, the first 224 aa of the *hok1* gene, and a C-terminal EGFP plus the *Tnos* terminator. The plasmid pHok1^1--224^G was linearized with SspI and integrated in the succinate dehydrogenase locus of strain AB33ΔHok1_mChRab5a and AB33_mChTub1, resulting in AB33ΔHok1_mChRab5a_Hok1^1--224^G and AB33_mChTub1_Hok1^1--224^G, respectively.

### pHok1^1--624^G.

This plasmid contains a region encoding the first 624 aa of Hok1, fused to EGFP. To obtain the plasmid, a 2,934-bp region, encoding the *hok1* promoter (−1,002 bp) and the first 624 aa of Hok1, was amplified from genomic DNA of *U. maydis* strain 521, using primers ~f~EB408-~r~EB405. A region encoding EGFP, the *Tnos* terminator, and a fragment of the carboxin resistance cassette was amplified from the plasmid pKin3G ([@bib80]), using primers ~f~EB407-~r~EB14, and was cloned into the pNEBcbx-yeast-SspI plasmid, digested with EcoRI and SacI, by in vivo recombination in the yeast *S. cerevisiae* FY834. The plasmid pHok1^1--624^G was linearized with AgeI and integrated into the succinate dehydrogenase locus of strains AB33ΔHok1_mChRab5a and AB33mCh~3~Dyn2_ΔHok1, resulting in AB33ΔHok1_mChRab5a_Hok1^1--624^G and AB33mCh~3~Dyn2_ΔHok1_Hok1^1--624^G, respectively.

### pHok1^225--624^G.

This plasmid contains a region encoding a middle domain of Hok1, fused to EGFP. To obtain the plasmid, a 1,035-bp region, encoding *hok1* promoter (−1,002 bp) and a region of 225--624 aa of Hok1, was amplified from genomic DNA of *U. maydis* strain 521, using primers ~f~EB408-~r~EB418. A region encoding EGFP, the *Tnos* terminator, and a fragment of the carboxin resistance cassette was amplified from the pKin3G plasmid ([@bib80]), using primers ~f~EB419-~r~EB14, and was cloned into the pNEBcbx-yeast-SspI plasmid, digested with EcoRI and SacI, by in vivo recombination in the yeast *S. cerevisiae* FY834. The plasmid pHok1^225--624^G was linearized with SspI and integrated into the succinate dehydrogenase locus of strain AB33ΔHok1_mChRab5a, resulting in AB33ΔHok1_mChRab5a_Hok1^225--624^G.

### pHok1^1--624^PXG.

This plasmid contains a region encoding first 624 aa from Hok1 and the PX domain from Yup1 ([@bib78]), fused to EGFP. To obtain the plasmid pHok1^1--624^PXG, a 2,935-bp region, encoding the *hok1* promoter (−1,002 bp) and the first 624 aa of Hok1, was amplified from the genomic DNA of *U. maydis* strain 521, using primers ~f~EB408-~r~EB402. A 438-bp region, encoding the PX domain from the endosomal t-SNARE Yup1 (aa 4--148) and flanking overhangs, was amplified from the pSl-Yup-RFP-hygromycin plasmid (provided by U. Fuchs) using primers ~f~EB403-~r~EB294. A region encoding EGFP, the *Tnos* terminator, and a fragment of the carboxin resistance cassette was amplified from the pKin3G plasmid ([@bib80]), using primers ~f~EB111-~r~EB14, and cloned into the pNEBcbx-yeast-SspI plasmid, digested with EcoRI and SacI, by in vivo recombination in the *S. cerevisiae* strain FY834. The plasmid pHok1^1--624^PXG was linearized with SspI and integrated into the succinate dehydrogenase locus of strain AB33ΔHok1_mChRab5a, resulting in AB33ΔHok1_mChRab5a_Hok1^1--624^PXG.

### po^C^~m~ChRab5a.

This plasmid contains mCherry fused to *rab5a*. To obtain it, plasmid popaGRab5a ([@bib55]) was digested with NdeI and AgeI, which provided the *rab5a* gene, its terminator, and half of the plasmid backbone, containing half of the carboxin and the ampicillin resistance cassettes and the *E. coli* replication origin (a 4,337-bp fragment). The same plasmid was digested with AgeI and NcoI to receive a 2,338-bp fragment, containing the second half of the backbone with the second half of the carboxin resistance cassette and the *potef* promoter. To replace the photoactivatable GFP with a single mCherry, the plasmid po~m~ChRab5a ([@bib57]) was digested with NcoI and NdeI (a 732-bp fragment). After a three-fragment ligation, the resulting plasmid carried the constitutive *potef* promoter followed by mCherry, the open reading frame, and the terminator of the *rab5a* gene. The plasmid was linearized with SspI and ectopically integrated into AB33G~3~Dyn2_ΔHok1, resulting in AB33G~3~Dyn2_ΔHok1_mChRab5a.

### pHok1^Δ225--624^G.

This plasmid contains the *hok1* gene, truncated in the middle region (Δ225--624 aa), fused to EGFP. To obtain the plasmid, a 1,704-bp region encoding the *hok1* promoter (−1,002 bp) and a region of 1--224 aa of Hok1 was amplified from genomic DNA of *U. maydis* strain 521, using primers ~f~EB408-~r~EB413. A remaining 978-bp region, encoding aa 625--930, was amplified from genomic DNA of *U. maydis* strain 521, using primers ~f~EB428-~r~EB375. A region containing EGFP, the *Tnos* terminator, and a fragment of the carboxin resistance cassette was amplified from the pKin3G plasmid ([@bib80]), using primers ~f~EB389-~r~EB14, and was cloned into the pNEBcbx-yeast-SspI plasmid, digested with EcoRI and SacI, by in vivo recombination in the *S. cerevisiae* strain FY834. The plasmid pHok1^Δ225--624^G was linearized with SspI and integrated into the succinate dehydrogenase locus of strain AB33ΔHok1_mChRab5a, resulting in AB33ΔHok1_mChRab5a_Hok1^Δ225--624^G.

### pHok1^1--224^PXG.

This plasmid contains a region encoding the first 224 aa from Hok1 and the lipid-binding PX domain from Yup1 ([@bib78]), fused to EGFP. To obtain this plasmid, pHok1^1--224^PX-HA was digested with AflII and BclI, providing a fragment containing the carboxin and ampicillin resistance cassettes, an *E. coli* replication origin, and the native promoter of the *hok1* gene (a 7,990-bp fragment). The same plasmid was digested with BclI and NcoI to obtain a region encoding the first 224 aa of the *hok1* gene and a region encoding 4--148 aa of the *yup1* gene (a 1,291-bp fragment). The EGFP gene was obtained by digestion of the plasmid p123 ([@bib1]) with NcoI and AflII (a 769-bp fragment). After a three-fragment ligation, the plasmid pHok1^1--224^PXG was digested with SspI and integrated ectopically into strain AB33ΔHok1_mChRab5a, resulting in AB33ΔHok1_mChRab5a_Hok1^1--224^PXG.

### pHok1^Δ361--385^G.

This plasmid contains the *hok1* gene, truncated in the conserved amino acid stretch (Δ361--385) and fused to EGFP. To obtain the plasmid, a 2,112-bp region encoding the *hok1* promoter (−1,002 bp) and 1--360 aa of Hok1 was amplified from genomic DNA of *U. maydis* strain 521 using primers ~f~EB408-~r~EB426. The remaining 1,695 bp, encoding a region of 386--930 aa, was amplified from genomic DNA of *U. maydis* strain 521 using primers ~f~EB427-~r~EB375. A region containing EGFP, the *Tnos* terminator, and a fragment of the carboxin resistance cassette was amplified from the pKin3G plasmid ([@bib80]) using primers ~f~EB389-~r~EB14 and was cloned into the pNEBcbx-yeast-SspI plasmid, digested with EcoRI and SacI, by in vivo recombination in the yeast *S. cerevisiae* FY834. The plasmid pHok1^Δ361--385^G was linearized with SspI and integrated into the succinate dehydrogenase locus of strain AB33ΔHok1_mChRab5a, resulting in AB33ΔHok1_mChRab5a_Hok1^Δ361--385^G.

### pHok1^Δ333--355^G.

This plasmid contains the *hok1* gene truncated in the conserved amino acid stretch (Δ333--355 aa), fused to EGFP. To obtain the plasmid, a 2,028-bp region, encoding *hok1* promoter (−1,002 bp) and 1--332 aa of Hok1, was amplified from genomic DNA of *U. maydis* strain 521 using primers ~f~EB408-~r~EB424. The remaining 1,786 bp, encoding a region of aa 356--930, was amplified from genomic DNA of *U. maydis* strain 521 using primers ~f~EB425-~r~EB375. A region containing EGFP, the *Tnos* terminator, and a fragment of the carboxin resistance cassette was amplified from the pKin3G plasmid ([@bib80]) using primers ~f~EB389-~r~EB14 and was cloned into the pNEBcbx-yeast-SspI plasmid, digested with EcoRI and SacI, by in vivo recombination in the yeast *S. cerevisiae* FY834. The plasmid pHok1^Δ333--355^G was linearized with SspI and integrated into the succinate dehydrogenase locus of strain AB33ΔHok1_mChRab5a, resulting in AB33ΔHok1_mChRab5a_Hok1^Δ333--355^G.

### pHk^361--385^.

This plasmid contains a sequence encoding a short and conserved region of Hok1, fused behind the inducible *crg* promoter ([@bib6]). The construct was obtained by amplification of a 134-bp fragment, encoding aa 361--385 of Hok1 and containing 30 bp of the *crg* promoter and the *Tnos* terminator, from genomic DNA of *U. maydis* strain 521 using primers ~f~EB422-~r~EB423. The fragment was cloned into the yeast vector pcrgPeb1^211--268^ ([@bib55]) by using in vivo recombination in the yeast *S. cerevisiae*. The plasmid pHk^361--385^ was digested with AgeI and integrated ectopically into strains AB33_mChRab5a_Hok1G, AB33GRab5a ([@bib55]), and AB33Kin3G ([@bib56]), resulting in AB33_mChRab5a_Hok1G\_↑pHk^361--385^, AB33GRab5a\_↑pHk^361--385^, and AB33Kin3G\_↑pHk^361--385^, respectively. The integration of the peptide construct was confirmed by PCR.

### pHok1^Δ361--385^HA.

This plasmid contains the *hok1* gene, truncated in the conserved stretch of aa 361--385, fused to human influenza HA tag. To replace EGFP and integrate the HA tag, the plasmid pHok1^Δ361--385^G was digested with AgeI and cloned with a 462-bp fragment (containing the AgeI restriction site) near the 3′ end of the gene, with a 96-bp fragment encoding HA tag and the overhangs and with a 1,470-bp region encoding the *Tnos* terminator and a part of the carboxin resistance cassette. All three fragments were amplified from the plasmid pHok1^Δ361--385^G using sets of primers ~f~EB388-~r~EB469, ~f~AB90-~r~AB97, and ~f~EB370-~r~SK49, respectively. The plasmid pHok1^Δ361--385^HA was linearized with SspI and integrated into the succinate dehydrogenase locus of AB33Kin3G_ΔHok1, resulting in AB33Kin3G_ΔHok1_Hok1^Δ361--385^.

### pHok1^H3_1--600^G.

This plasmid contains the carboxin resistance cassette, the C terminus of the *hok1* (aa 625--930), and a 600-aa region amplified from human *hook3* (aa 1--600) followed by *egfp*. To obtain the plasmid, pHok1^Δ361--385^G was digested with MscI and BclI and fused to a 222-bp fragment, amplified from the plasmid pHok1^Δ361--385^G, a 1,861-bp fragment encoding the first 600 aa amplified from human HeLa cDNA, and a 772-bp region encoding a part of the *hok1* C terminus, amplified from the plasmid pHok1^Δ361--385^G using sets of primers ~f~EB416-~r~EB418, ~f~EB463-~r~EB464, and ~f~EB452-~r~EB453, respectively. The plasmid pHok1^H3_1--600^G was linearized with SspI and integrated into the succinate dehydrogenase locus of AB33ΔHok1_mChRab5a, resulting in AB33ΔHok1_mChRab5a_Hok1^H3_1--600^G.

### pHok1^H3_166--436^G.

This plasmid contains the carboxin resistance cassette and the *hok1* gene truncated in the CC region (Δ225--624 aa), which was replaced with a 271-aa region amplified from human *hook3* (aa 166--436) followed by EGFP. To obtain the plasmid, pHok1^Δ361--385^G was digested with MscI and PflMI and fused to a 400-bp fragment encoding a part of the N terminus of *hok1*, amplified from the plasmid pHok1^Δ361--385^G, a 873-bp fragment encoding the region of aa 166--436, amplified from human HeLa cDNA, and a 772-bp region encoding a part of the *hok1* C terminus, amplified from the plasmid pHok1^Δ361--385^G using sets of primers ~f~EB451-~r~EB413, ~f~EB449-~r~EB450, and ~f~EB452-~r~EB453, respectively. The plasmid pHok1^H3_166--436^G was linearized with SspI and integrated into the succinate dehydrogenase locus of AB33ΔHok1_mChRab5a, resulting in AB33ΔHok1_mChRab5a_Hok1^H3_166--436^G.

### pHok1^H3_293--345^G.

This plasmid contains the carboxin resistance cassette and the *hok1* gene truncated in the conserved amino acid stretch (Δ333--385 aa), which was replaced with a 53-aa region amplified from human *hook3* (aa 293--345) followed by EGFP. To obtain the plasmid, pHok1^Δ361--385^G was digested with MscI and PspXI and fused to a 724-bp fragment, amplified from the plasmid pHok1^Δ361--385^G, a 221-bp fragment encoding the conserved stretch amplified from human HeLa cDNA, and a 1,489-bp region encoding EGFP, the *Tnos* terminator, and a part of the carboxin resistance cassette, amplified from the plasmid pHok1^Δ361--385^G using sets of primers ~f~EB451-~r~EB424, ~f~EB455-~r~EB456, and ~f~EB454-~r~EB453, respectively. The plasmid pHok1^H3_293--345^G was linearized with SspI and integrated into the succinate dehydrogenase locus of AB33ΔHok1_mChRab5a, resulting in AB33ΔHok1_mChRab5a_Hok1^H3_293--345^G.

### pFts1G.

This plasmid contains a 1,176-bp fragment near the 3′ end of the *fts1* gene followed by EGFP, the *Tnos* terminator, the hygromycin resistance cassette, and a 1,077-bp downstream sequence of the *fts1* gene. The plasmid was generated through in vivo recombination in the yeast *S. cerevisiae* FY834. Fragments 1,176 and 1,077 bp were amplified with 30-bp overhangs from genomic DNA of the *U. maydis* strain 521 using sets of primers ~f~EB490-~r~EB491 and ~f~EB483-~r~EB484, respectively, and cloned with a 4,101-bp fragment encoding EGFP, the *Tnos* terminator, and the hygromycin cassette and a 4,899-bp fragment encoding an ampicillin resistance cassette, an *E. coli* replication origin, the yeast URA3 marker, and 2µ *ori*. Both fragments were derived from the plasmid pKin3G_H ([@bib56]) by digestion with SacI and PmlI (a 4,101-bp fragment) and with PsiI and SacI (a 4,899-bp fragment). The plasmid pFts1G was digested with PsiI and BamHI and homologously integrated into the *fts1* locus of strain AB33_mChRab5a, resulting in AB33_mChRab5a_Fts1G. Integration into the *fts1* locus was confirmed by PCR and Southern blotting.

### pFhp1G.

This plasmid contains a 1,082-bp fragment near the 3′ end of the *fhp1* gene followed by EGFP, the *Tnos* terminator, the hygromycin resistance cassette, and a 1,074-bp downstream sequence of the *fhp1* gene. The plasmid was generated through in vivo recombination in the yeast *S. cerevisiae* FY834. Fragments 1,082 and 1,074 bp were amplified with 30-bp overhangs from genomic DNA of the *U. maydis* strain 521 using sets of primers ~f~EB492-~r~EB493 and ~f~EB494-~r~EB495, respectively, and cloned with a 4,101-bp fragment encoding EGFP, the *Tnos* terminator, and the hygromycin cassette and a 4,899-bp fragment encoding an ampicillin resistance cassette, an *E. coli* replication origin, the yeast URA3 marker, and 2µ *ori*. Both fragments were derived from the plasmid pKin3G_H ([@bib56]) by digestion with SacI and PmlI (a 4,101-bp fragment) and with PsiI and SacI (a 4,899-bp fragment). The plasmid pFhp1G was digested with PsiI and BamHI and homologously integrated into the *fhp1* locus of strain AB33_mChRab5a, resulting in AB33_mChRab5a_Fhp1G. Integration into the *fhp1* locus was confirmed by PCR and Southern blotting.

### p^C^ΔKin3.

To replace the nourseothricin resistance cassette with carboxin, plasmid pΔKin3 ([@bib57]) was digested with NotI. The obtained plasmid p^C^ΔKin3 was digested with KpnI and SphI and integrated into the strain AB33_mChRab5a_Hok1G, resulting in AB33_mChRab5a_Hok1G_ΔKin3. Integration into the *kin3* locus was confirmed by PCR and Southern blotting.

UV mutagenesis
--------------

The *U. maydis* strain AB33_GRab5a, expressing ectopically integrated GFP-Rab5a, was plated onto 120 × 120--mm complete medium agar plates containing 1% (wt/vol) glucose, at ∼6,000 cells per plate. To obtain a survival curve, cells were UV radiated using an ultraviolet cross-linker (wavelength, 254 nm; CL 508S; UVITEC) at 20--55 mJ/cm^2^ and grown in the dark. 32 mJ/cm^2^ results in 3% survival and was used to mutagenize strain AB33_GRab5a. Colonies were grown in darkness for 5--6 d and, subsequently, replica plated onto NM plates supplemented with glucose. After 3--4 d at 28°C, colonies showing the short hyphal growth phenotype were selected and microscopically investigated.

Sequencing
----------

Whole genome sequencing was performed using genomic DNA, which was isolated as previously described ([@bib29]). 2 µg DNA was diluted in TE buffer (Tris-EDTA; 200-µl total volume) and fragmented using a Bioruptor (Diagenode) at a 30-min cycle of medium power of 30 s on and 30 s off on ice. DNA was concentrated and purified using a QIAquick column (QIAGEN), and fragmentation of the DNA was confirmed using the DNA chip (Bioanalyzer 7500; Agilent Technologies). A sequencing library was prepared using SPRIworks (Beckman Coulter) with a 300--600-bp size selection. The library was amplified for 15 cycles of PCR using Phusion DNA polymerase (New England Biolabs, Inc.) and purified using 0.8 volumes AMPure XP beads (Beckman Coulter). The mean (mode) insert size of the library was 279 bp (ranging between 200 and 600 bp) and was determined using a Bioanalyzer 7500 DNA chip. The library was pooled with other bar-coded libraries, denatured, and diluted to 5.5 pmol clustered on a cBot (Illumina, Inc.). 50-bp paired-end sequencing, with a custom bar-coding read, was completed on a HiSeq 2000 (Illumina, Inc.) using TruSeq v3 reagents (Illumina, Inc.). Reads were demultiplexed, using the CASAVA 1.8 software pipeline (Illumina, Inc.) into FASTQ files. This allowed zero mismatches in the bar codes with 29,853,306 numbers of reads, which were filtered using the fastq-mcf program from the ea-utils package, applying --x 0.01, --q 20, --p 10, and --u. Reads were subsequently remapped to the *U. maydis* reference genome from the Munich Information Center for Protein Sequences *Ustilago maydis* Genome Database using the BWA (Burrows--Wheeler Aligner; [@bib42]), using the settings bwa aln --t 8 --q 20 and bwa sampe --a 600. Conversion from SAM to BAM files, duplicate PCR read removal, and mpileup files were generated using the SAMtools software package ([@bib43]). Bespoke perl scripts were used to identify SNPs using mpileup files (based on minimum read depth of 10 and minimum base identity of 95%) and identify which genes they occurred in. Positions that showed a base difference between the mutant strain (EMD5) and strain AB33G_GRab5a were considered as candidates for the mutations that produced observed phenotypic differences.

Identification of mutations in the EMD5 mutant
----------------------------------------------

Genomic DNA were extracted from mutant EMD5 and *U. maydis* strain AB33_GRab5a and sequenced using a HiSeq 2000. Short reads were aligned against the published genome, and SNPs were discovered, based on minimum read depth of 10 and minimum base identity of 95%.

Laser-based fluorescence microscopy
-----------------------------------

Fluorescence microscopy was performed as previously described ([@bib55]). In brief, the fungal cells were placed onto a 2% agar cushion and directly observed using a motorized inverted microscope (IX81; Olympus), equipped with a Plan Apochromat 100×, 1.45 NA oil total internal reflection fluorescence objective or U Plan S Apochromat 60×, 1.35 NA oil objective (Olympus). The fluorescent tags were exited using a VS-LMS4 Laser Merge System with solid-state lasers (488 nm/50 mW or 75 mW and 561 nm/50 mW or 75 mW; Visitron Systems). Photobleaching experiments were performed using a 405-nm/60-mW diode laser, which was decreased by a neutral density 0.6 filter, resulting in 15-mW output power, coupled into the light path by an adaptor (OSI-IX 71; Visitron Systems). The 405-nm laser was controlled by a controller (UGA-40; Rapp OptoElectronic) and VisiFRAP 2D FRAP control software for Meta Series 7.5.x (Visitron Systems). Synchronized observation of RFP and GFP fluorescence was performed using an imager (Dual-View Micro; Photometrics) equipped with a dual-line beam splitter (z491/561; Chroma Technology Corp.) with an emission beam splitter (565 DCXR; Chroma Technology Corp.), an ET-Band pass 525/50 (Chroma Technology Corp.), and a single band pass filter (BrightLine HC 617/73; Semrock). Images were captured using a camera (CoolSNAP HQ^2^; Photometrics/Roper Scientific). All parts of the system were under the control of the software package MetaMorph (Molecular Devices). Unless otherwise noted, all statistical analysis was performed using Mann--Whitney testing, and all values given in the text are means ± SD of at least two experiments. All statistical analysis was performed using Prism 4.03 (GraphPad Software).

Protein colocalization experiments
----------------------------------

Colocalizations of EEs and Hok1, the truncated protein Hok1^1--624^G, or the chimeras of Hok1^1--624^-PXG and Hok1^H3_293--345^G cells were performed using the strains AB33_mChRab5a_Hok1G, AB33ΔHok1_mChRab5a_Hok1^1--624^G, AB33ΔHok1_mChRab5a_Hok1^1--624^-PXG, and AB33ΔHok1_mChRab5a_pHok1^H3_293--345^G. The strains were placed onto a 2% agar cushion and transferred to the microscope. A region of 10 µm in length 5 µm behind the hyphal tip was photobleached by a 100-ms light pulse of the 405-nm laser (60 mW) at 80% laser power. Subsequently, 100 frames were taken using a Dual-View Micro imager, with the 488-nm laser (90% output) and the 561-nm laser (25% output power) at a 150-ms exposure time, binning of 2. Colocalization kymographs were generated from the acquired image series using the MetaMorph software.

To colocalize dynein with the truncated protein Hok1^1--624^G, cells of strain AB33mCh~3~Dyn2_ΔHok1_Hok1^1--624^G were placed onto a 2% agar cushion and transferred to the microscope. A region of 30--40 µm in length 3 µm behind the hyphal tip was photobleached by a 100-ms light pulse of the 405-nm laser (80% laser power). Subsequently, 50 frames were taken using the Dual-View Micro imager, with the 488-nm laser (90% output power) and the 561-nm laser (80% output power) at a 150-ms exposure time, binning of 2. Kymographs were generated from the acquired image series using the MetaMorph software.

Colocalization between Fts1 and EEs and Fhp1 and EEs was analyzed in strains AB33_mChRab5a_Fts1G and AB33_mChRab5a_Fhp1G, respectively, by photobleaching of a region of hyphae behind the hyphal tip, using a 100-ms laser pulse (405-nm laser and 100% output power) followed by acquisition of 150 frames, using the Dual-View Micro imager, the 488-nm laser at 100% output power, a 561-nm laser at 25% output power, an exposure time of 150 ms, and binning of 2.

Colocalization kymographs were generated using the MetaMorph software. To determine the colocalization of apical dynein and EEs in Δ*hok1* mutants, MTs were disrupted during microscopic observation by incubating hyphal cells of the AB33G~3~Dyn2_ΔHok1_mChRab5a strain for 5--7 min in liquid media containing 30 µM benomyl (Sigma-Aldrich) and placed on a 2% agar cushions, supplemented with benomyl, for microscopic observation.

Analysis of motor and EE motility
---------------------------------

Retrograde flux of dynein was analyzed in control strain AB33G~3~Dyn2 and the Δ*hok1* mutant AB33G~3~Dyn2_ΔHok1. Cells were placed onto a 2% agar cushion and transferred to the microscope. A region of 15 µm in length 5 µm behind the hyphal tip was photobleached by a 100-ms light pulse of the 405-nm laser (80% laser power) followed by immediate observation using the 488-nm laser (100% output power), at 150-ms exposure time and binning of 1. Flux rates were determined in kymographs, generated using the MetaMorph software.

To analyze retrograde and anterograde flux in strains AB33_mChRab5a_Hok1G and AB33ΔHok1_mChRab5a_Hok1^1--624^G, cells were observed on 2% agar cushions. A region of 10 µm in length 5 µm behind the hyphal tip was photobleached, using a 100-ms light pulse of the 405-nm laser at 80% laser power followed by acquisition of 100 frames, using the 488-nm laser at 100% output power at 150-ms exposure time and binning of 1. Flux rates were determined in kymographs, generated using the MetaMorph software.

The flux of EEs was analyzed in strains AB33_mChRab5a_Hok1G, AB33ΔHok1_mChRab5a_Hok1^Δ333--355^G, AB33ΔHok1_mChRab5a_Hok1^Δ361--385^G, and AB33_mChRab5a_Hok1G\_↑pHk^361--385^. Cells were grown in their respective media, placed onto a 2% agar cushion, and transferred to the microscope. A region of 10 µm in length 5 µm behind the hyphal tip was photobleached, using a 100-ms, 405-nm laser pulse (80% output power) followed by observation, using the 561-nm laser at 50% output power at an exposure time of 150 ms and binning of 1. Flux rates were determined in kymographs, generated using the MetaMorph software.

EE run length was analyzed in strains AB33GRab5a ([@bib55]) and AB33GRab5a\_↑pHk^361--385^. Control cells were placed onto a 2% agar cushion and transferred to the microscope. To clear the cell from interfering signals, a region of 40--50 µm in length, starting ∼5 µm behind the hyphal tip, was photobleached using a 100-ms light pulse at 405 nm (80% laser output power). Subsequently, 150 frames were taken using the 488-nm laser at 25% output power at 150-ms exposure time and binning of 1. For strain AB33GRab5a\_↑pHk^361--385^, the expression of pHk^361--385^ was induced by shifting the cells for 2 h in 1% arabinose-containing media. After this, the cells were directly observed using the aforementioned conditions. Run length of the organelles was determined in kymographs, generated using the MetaMorph software.

Pausing time of dynein and EEs during anterograde to retrograde turning was analyzed in strain AB33G~3~Dyn2_mChRab5a. Cells were placed on a thin layer of 2% agarose, and regions of ∼10 µm at ∼5 µm behind the hyphal tip were photobleached, using a 100-ms laser pulse (405-nm laser and 80% output power) followed by acquisition of 75 frames, using the Dual-View Micro imager, a 488-nm laser at 80% output power, a 561-nm laser at 50% output power, an exposure time of 150 ms, and binning of 1. Pausing time of the organelles and motors was determined in kymographs, generated using the MetaMorph software.

EE turning was analyzed in the strain AB33GRab5a ([@bib55]) and measured in the first 10 µm of each hypha after photobleaching the region of the first 15 µm from the tip using a 100-ms laser pulse (405-nm laser and 100% output power) followed by acquisition of 150 frames, using the 488-nm laser at 50% output power at an exposure time of 150 ms and binning of 1. Antero- to retrograde turning of EEs was determined in kymographs, generated using the MetaMorph software.

Hyphal cell length was measured in strains AB33ΔHok1_Hok1G, AB33ΔHok1_mChRab5a_Hok1^1--624^PXG, and AB33ΔHok1_mChRab5a, which were grown up overnight in NM liquid medium containing 1% glucose (wt/vol). In the case of bipolar hyphae of the mutant strains, only longer hypha was measured using MetaMorph software.

Analysis of motor and Hok1 numbers
----------------------------------

Quantitative analysis of fluorescent intensities of kinesin-3, Hok1, and dynein numbers of Kin3-GFP, Hok1-GFP, and GFP~3~Dyn2 was performed using the nucleoporin Nup107-GFP as an internal calibration standard, following published procedures ([@bib55]). Strain FB2NupG was placed on a 2% agar cushion, and images of Nup107-GFP at the upper level of the nucleus were acquired with a 150-ms exposure time. The integrated intensity of single weak Nup107-GFP signals, representing 16 Nup107-GFP in a single nuclear pore, was corrected for the adjacent background. Corrected values were plotted, and the mean integrated intensity for a single Nup107-GFP was estimated. The fluorescent intensities of moving signals of Kin3-GFP, Hok1-GFP, and GFP~3~Dyn2 were determined in strains AB33Kin3G ([@bib56]), AB33Kin3G\_↑pHk^361--385^, AB33Kin3G_Hok1^Δ361--385^, AB33Kin3G_ΔHok1, AB33_mChRab5a_Hok1G, AB33G~3~Dyn2_mChRab5a ([@bib57]), and AB33G~3~Dyn2_ΔHok1_mChRab5a. Cells were grown in their respective media, placed onto a 2% agar cushion, and transferred to the microscope. The first 10 µm of the hypha was photobleached by a 100-ms light pulse of the 405-nm laser (80% laser output power). After 5 s, an image series of 15 frames was taken, using the 488-nm laser at 100% output power and an exposure time of 150 ms, with binning of 1. Signals that were in focus in the first plane and that moved toward the hyphal tip were considered. For retrograde moving of Kin3-GFP and GFP~3~Dyn2 signals, a region of 10 µm, 5 µm behind the hyphal tip, was photobleached by a 100-ms light pulse of the 405-nm laser (80% laser output power). After 5 s, an image series of 15 frames was taken, using the 488-nm laser at 100% output power and an exposure time of 150 ms, with binning of 1. Signals that were in focus in the first plane and that moved toward the hyphal tip were considered. The integrated intensity value for these signals was measured in the first frame and corrected by the adjacent background. The numbers of Kin3-GFP and Hok1-GFP were estimated by comparing their fluorescent intensities to the mean intensity of a single Nup107-GFP. This also took into account that Kin3 and Hok1 are most likely dimers ([@bib83]; [@bib24]).

Fluctuation of Kin3-GFP and Hok1-GFP fluorescence during anterograde to retrograde turning was performed using kymographs. The integrated intensity in each plane was measured and corrected for the adjacent background and for frame-to-frame bleaching, which was determined in each kymograph.

Visualizing the endocytic pathway
---------------------------------

Endocytic sorting was analyzed in strains AB33GRab5a ([@bib55]), AB33GRab5a_ΔHok1, AB5Dyn2^ts^\_GRab5a, AB33GRab7 ([@bib26]), and AB33ΔHok1_GRab7. Hyphal growth was induced by adding a1/a2 pheromone at a final concentration of 2.5 µg/ml ([@bib21]) and incubated for 3--4 h at 22°C. After hyphae formation, the dye FM4-64 (Invitrogen/Molecular Probes) was added to 500-µl cultures at a final concentration of 1 µg/ml ([@bib78]). Cells were incubated for 10 min and sedimented at 3,000 rpm for 1 min. Subsequently, they were washed with 500 µl of fresh media followed by 20-min incubation in dye-free media. The vacuoles were labeled with CellTracker blue CMAC (7-amino-4-chloromethylcoumarin; Invitrogen/Molecular Probes), which specifically stains the acidic vacuolar compartment in *U. maydis* ([@bib65]). The dye was added to the culture pretreated with FM4-64 with a final concentration of 20.9 µg/ml. Cells were incubated for 5 min and sedimented, washed, and placed onto a 2% agar cushion for microscopic observation.

Protein extraction, native gel electrophoresis, and Western blotting
--------------------------------------------------------------------

Expression of Hok1 proteins was confirmed by Western Blotting. To this end, hyphal cell extracts were generated from 100-ml overnight cultures, grown to OD~600~ 0.5--1.8, by disruption of liquid nitrogen--frozen *U. maydis* cells in a mixer mill (MM400; Retsch) at 30/s for 2 × 2.5 min. Thawed cell extract, organelles, and cell debris were resuspended in 0.1--0.5 ml of 50 mM Hepes, 50 mM KCl, 1 mM EGTA, and 1 mM MgCl~2~, pH 7.0, complemented with protease inhibitor (cOmplete Mini; Roche). Debris was removed by centrifugation in a Heraeus Biofuge Stratos (Thermo Fisher Scientific), using rotor 3331 at 23,300 rpm for 30 min at 4°C. The protein concentration of the cell extracts was determined using protein assay reagent (500-0006; Bio-Rad Laboratories, Inc.), and ∼50 µg of each sample was loaded on 8% SDS-polyacrylamide gels. This was followed by transfer to nitrocellulose membrane (GE Healthcare) for 45 min at 190 mA in a semidry blot chamber (Fastblot; Analytik Jena). Each blot was blocked for 1 h with 5% nonfat milk in TBS--1% Tween 20 and incubated overnight at 4°C with anti-GFP mouse IgG monoclonal antibodies in a 1:5,000 dilution (11814460001; Roche) or anti-HA high affinity rat monoclonal antibodies in a 1:1,000 dilution (11867423001; Roche) followed by incubation with HRP-conjugated anti--mouse IgG in a 1:4,000 dilution (W402B; Promega) or with HRP-conjugated goat anti--rat IgG in a 1:5,000 dilution (62-9520; Invitrogen) for 1--2 h at room temperature. The loading of even amounts of cell extract was confirmed, using of mouse anti--α-tubulin antibodies in a 1:4,000 dilution (Oncogene Science), followed by HRP-conjugated anti--mouse IgG in a 1:4,000 dilution. All blots were developed using ECL Plus Western Blotting Detection system, following the manufacturer's instructions (GE Healthcare).

To compare the migration of Hok1G, Hok1^Δ333--355^G, and Hok1^Δ361--385^G in 8% native gels, cell extract was prepared from strains AB33_mChRab5a_Hok1G, AB33ΔHok1_mChRab5a_Hok1^Δ361--385^G, and AB33ΔHok1_mChRab5a_Hok1^Δ361--385^G using BRB80 buffer (80 mM Pipes, 1 mM EGTA, and 1 mM MgCl~2~, pH 6.9), complemented with protease inhibitor (cOmplete Mini). ∼15 µg of each sample was loaded on 8% polyacrylamide gels lacking SDS. Proteins were detected by Western blotting.

Immunoprecipitation and mass spectrometry
-----------------------------------------

Interacting proteins were identified using Hok1-GFP and the GFP-Trap method (ChromoTek) followed by mass spectrometry. Cells were sedimented and disrupted using a mixer mill (MM400) twice for 2.5 min at a frequency of 30/s in the presence of liquid nitrogen. Extraction buffer (10 mM Hepes, 50 mM KCl, 1 mM EGTA, and 1 mM MgCl~2~, pH 7.0, containing protease inhibitors) was added, and the mixture was centrifuged for 30 min at 50,000 *g* at 4°C. The supernatant was collected, and the protein concentration was determined using a Bradford assay. Appropriate sample volumes were incubated with ChromoTek beads for 2 h at 4°C followed by three washes in extraction buffer. The beads were then analyzed by mass spectrometry. For this, proteins were subjected to an in-solution trypsin digest and analyzed using a quadrupole time of flight system (Q-TOF 6520; Agilent Technologies) coupled to a 1200 Series HPLC-Chip interface system. 1 µl was loaded onto a micro-C18 reverse-phase analytical column (75 µm × 150 mm; Protein ID Chip; Agilent Technologies). A hit was regarded as a probable identification when a minimum of two unique peptides achieved a score of \>7 with matching forward--reverse values and percentage of score peak intensities \>60%. For further details see [@bib11]. The *U. maydis* protein database was obtained from the Munich Information Center for Protein Sequences *Ustilago maydis* Genome Database.

Bioinformatics
--------------

All sequences were obtained from the NCBI Protein Database with the following accession numbers: (a) Hook protein sequences: *U. maydis* Hok1 (um05551.1), [XP_761698](XP_761698); *D. melanogaster* Hook and human Hook1, [AAC09298](AAC09298); human Hook3, [NP_115786](NP_115786); *Salpingoeca* sp., [XP_004988159](XP_004988159); *A. laibachii*, [CCA23185](CCA23185); *Mus musculus* Hook3, [NP_997542](NP_997542); *Gallus gallus*, [XP_003643087](XP_003643087); *Xenopus laevis*, [NP_001085515](NP_001085515); *Strongylocentrotus purpuratus*, [XP_796541](XP_796541); *Aspergillus fumingatus*, [XP_750495](XP_750495); *Neurospora crassa*, [XP_956252](XP_956252); *Hordeum vulgare*, [BAK00177](BAK00177); and *Branchiostoma floridae*, [XP_002602613](XP_002602613). (b) Non-Hook proteins that are first hits in BLAST when using human Hook1: *Physcomitrella patens*, [XP_001758626](XP_001758626); *Arabidopsis thaliana*, [XP_002887245](XP_002887245); *C. albicans*, [XP_710120](XP_710120); *S. cerevisiae* Btn2p, [EEU04378](EEU04378); *A. gossypii* FDAG1, [AEY95210](AEY95210); and *S. pombe*, [Q09684](Q09684). (c) Kinesin-3 protein sequences: *Salpingoeca* sp., [XP_004997839](XP_004997839); human Kif1A, [NP_001230937](NP_001230937); *M. musculus* Kif1A, [NP_032466](NP_032466); *G. gallus* Kif1A-like, [XP_003641781](XP_003641781); *D. melanogaster* Unc104-like, [NP_611155](NP_611155); *X. laevis*, [NP_001138546](NP_001138546); *U. maydis* Kin3, [XP_762398](XP_762398); *N. crassa* Kin2, [ESA42610](ESA42610)*; A. nidulans*, [XP_680816](XP_680816); *S. purpuratus*, [XP_003728932](XP_003728932); *B. floridae*, [XP_002602366](XP_002602366); and *A. laibachii*, [CCA17471](CCA17471). (d) Kinesin motors with the highest e-values when compared with the human Kif1A motor domain: *H. vulgare*, [BAK04987](BAK04987); *C. albicans*, [XP_713761](XP_713761); *A. gossypii*, [NP_984241](NP_984241); *A. thaliana*, [CAB88133](CAB88133); *P. patens*, [XP_001754280](XP_001754280); and *S. pombe*, [NP_594686](NP_594686). (e) Hook-interacting proteins: *U. maydis* UmFhp1, [XP_757710](XP_757710); human HsFHIP_1, [NP_115503](NP_115503); *U. maydis* UmFts1, [XP_756598](XP_756598); and human HsFTS_b, [EAW82809](EAW82809).

The degree of sequence identity and similarity between proteins was determined by using EMBOSS Needle. The protein domain predictions were performed in InterProScan and Pfam (<http://pfam.sanger.ac.uk/search>), CCs were predicted by the COILS server, sequence alignments were performed using ClustalW, and the isoelectric point of the conserved region in the CC of *Ustilago* Hok1 was estimated using the EXPASY server (<http://web.expasy.org/compute_pi/>). The phylogenetic tree was calculated in MEGA 5.10 ([@bib69]). Sequence searches were performed in in BLAST (basic local alignment search tool; NCBI).

Online supplemental material
----------------------------

Fig. S1 shows a schematic overview of kinesin-3 and dynein in mediating bidirectional EE motility in *U. maydis*. Fig. S2 provides additional information on the genetic screen, including the phenotype of kinesin-3 and dynein mutants, the appearance of the EMD5 mutant on plates, and the rescue of EMD5 and Δ*hok1* by wild-type Hok1. Fig. S3 shows Western blots of cell extracts from Δ*hok1* mutants expressing various Hok1 mutant proteins. Fig. S4 shows the colocalization of the N-terminal domain of Hok1 and MTs, additional kymographs of retrograde motility of dynein in control and Δ*hok1*, and the domain organization and EE localization of the Hok1-interacting proteins Fts1 and Fhp1. Fig. S5 shows the phenotype of a Δ*hok1* mutant expressing Hok1^Δ333--355^, the position of Hok1, Hok1^Δ333--355^, and Hok1^Δ361--385^ in a native polyacrylamide gel, the localization of Hok1 on Rab5a-positive EEs in a kinesin-3--null mutant, and the position of anterograde to retrograde EE turnings within the apical 10 µm, at which MTs are unipolar. Table S1 shows the experimental usage of all strains, and Table S2 summarizes the primers used for cloning. Videos show bidirectional motility of EEs in wild-type, EMD5, and Δ*hok1* mutants (Video 1), localization of Hok1 on EEs (Video 2), localization of the chimeric protein Hok1^1--624^PX on moving EEs (Video 3), covisualization of cytoplasmic dynein and EEs in Δ*hok1* (Video 4), covisualization of Hok1^1--624^GFP and EE (Video 5) and Hok1^1--624^GFP and dynein in Δ*hok1* mutants (Video 6), EE motility in the presence of the peptide pHk1^361--385^ (Video 7), and covisualization of Hok1^HsH3_293--345^ and EEs in Δ*hok1* mutants (Video 8). Online supplemental material is available at <http://www.jcb.org/cgi/content/full/jcb.201309022/DC1>.
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